NO121611B - - Google Patents
Download PDFInfo
- Publication number
- NO121611B NO121611B NO1936/68A NO193668A NO121611B NO 121611 B NO121611 B NO 121611B NO 1936/68 A NO1936/68 A NO 1936/68A NO 193668 A NO193668 A NO 193668A NO 121611 B NO121611 B NO 121611B
- Authority
- NO
- Norway
- Prior art keywords
- triiodo
- acetylamino
- acid
- phenoxy
- calculated
- Prior art date
Links
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 27
- -1 amino-triiodophenoxy compounds Chemical class 0.000 claims description 26
- 239000002253 acid Substances 0.000 claims description 18
- 239000002872 contrast media Substances 0.000 claims description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims description 13
- 150000001298 alcohols Chemical class 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 150000002148 esters Chemical class 0.000 claims description 9
- 229910052751 metal Inorganic materials 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 9
- 125000002252 acyl group Chemical group 0.000 claims description 8
- 150000007513 acids Chemical class 0.000 claims description 7
- 125000002947 alkylene group Chemical group 0.000 claims description 7
- 231100000252 nontoxic Toxicity 0.000 claims description 6
- 230000003000 nontoxic effect Effects 0.000 claims description 6
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 63
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 60
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 44
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 42
- 150000001875 compounds Chemical class 0.000 description 34
- 238000009835 boiling Methods 0.000 description 32
- 238000002844 melting Methods 0.000 description 28
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 27
- 230000008018 melting Effects 0.000 description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- 239000000243 solution Substances 0.000 description 24
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 23
- 229960003424 phenylacetic acid Drugs 0.000 description 23
- 239000003279 phenylacetic acid Substances 0.000 description 23
- 239000000741 silica gel Substances 0.000 description 23
- 229910002027 silica gel Inorganic materials 0.000 description 23
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 22
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 21
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- 239000000126 substance Substances 0.000 description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 10
- 238000001953 recrystallisation Methods 0.000 description 10
- 229960000583 acetic acid Drugs 0.000 description 9
- 210000000941 bile Anatomy 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- 239000012362 glacial acetic acid Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 8
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 8
- 238000007127 saponification reaction Methods 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000000052 vinegar Substances 0.000 description 8
- 235000021419 vinegar Nutrition 0.000 description 8
- 125000004494 ethyl ester group Chemical group 0.000 description 7
- 238000001704 evaporation Methods 0.000 description 7
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 125000004433 nitrogen atom Chemical group N* 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- 159000000000 sodium salts Chemical class 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 229940005605 valeric acid Drugs 0.000 description 7
- 229940126062 Compound A Drugs 0.000 description 6
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- BPLPANYMHXJFOX-UHFFFAOYSA-N N-(3-hydroxy-2,4,6-triiodophenyl)acetamide Chemical compound CC(=O)NC1=C(I)C=C(I)C(O)=C1I BPLPANYMHXJFOX-UHFFFAOYSA-N 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 6
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- NMOVGKYYUYVCKE-UHFFFAOYSA-N C(C)N(C=1C(=C(C(=CC=1I)I)O)I)C(C)=O Chemical compound C(C)N(C=1C(=C(C(=CC=1I)I)O)I)C(C)=O NMOVGKYYUYVCKE-UHFFFAOYSA-N 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 5
- 229940073608 benzyl chloride Drugs 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 229910052753 mercury Inorganic materials 0.000 description 5
- OSDZHDOKXGSWOD-UHFFFAOYSA-N nitroxyl;hydrochloride Chemical compound Cl.O=N OSDZHDOKXGSWOD-UHFFFAOYSA-N 0.000 description 5
- 238000005245 sintering Methods 0.000 description 5
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 5
- OIRFJRBSRORBCM-UHFFFAOYSA-N Iopanoic acid Chemical compound CCC(C(O)=O)CC1=C(I)C=C(I)C(N)=C1I OIRFJRBSRORBCM-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 125000006011 chloroethoxy group Chemical group 0.000 description 4
- 238000009606 cholecystography Methods 0.000 description 4
- PKLCHEAMZORRHK-UHFFFAOYSA-N ethyl 2-[2-(2-chloroethoxy)phenyl]acetate Chemical compound CCOC(=O)CC1=CC=CC=C1OCCCl PKLCHEAMZORRHK-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 229960002979 iopanoic acid Drugs 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000012266 salt solution Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- LPICKVRTXDYZBC-UHFFFAOYSA-N ethyl 2-(2-chloroethoxy)propanoate Chemical compound CCOC(=O)C(C)OCCCl LPICKVRTXDYZBC-UHFFFAOYSA-N 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 230000020477 pH reduction Effects 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 2
- 206010029155 Nephropathy toxic Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- JYYOBHFYCIDXHH-UHFFFAOYSA-N carbonic acid;hydrate Chemical compound O.OC(O)=O JYYOBHFYCIDXHH-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- HABMJDDTIXAKNH-UHFFFAOYSA-N ethyl 2-(2-chloroethoxy)butanoate Chemical compound C(C)OC(C(CC)OCCCl)=O HABMJDDTIXAKNH-UHFFFAOYSA-N 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 150000002497 iodine compounds Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000007694 nephrotoxicity Effects 0.000 description 2
- 231100000417 nephrotoxicity Toxicity 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- GHLRJTSNVRHHDT-UHFFFAOYSA-N 2-(2-chloroethoxy)-2-phenylacetonitrile Chemical compound ClCCOC(C1=CC=CC=C1)C#N GHLRJTSNVRHHDT-UHFFFAOYSA-N 0.000 description 1
- YHYJWNUPANUPSH-UHFFFAOYSA-N 2-(3-acetamido-2,4,6-triiodophenoxy)hexanoic acid Chemical compound CCCCC(C(O)=O)OC1=C(I)C=C(I)C(NC(C)=O)=C1I YHYJWNUPANUPSH-UHFFFAOYSA-N 0.000 description 1
- OCYJXSUPZMNXEN-UHFFFAOYSA-N 2-amino-1-(4-nitrophenyl)propane-1,3-diol Chemical compound OCC(N)C(O)C1=CC=C([N+]([O-])=O)C=C1 OCYJXSUPZMNXEN-UHFFFAOYSA-N 0.000 description 1
- LAMUXTNQCICZQX-UHFFFAOYSA-N 3-chloropropan-1-ol Chemical compound OCCCCl LAMUXTNQCICZQX-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- HSMNQINEKMPTIC-UHFFFAOYSA-N N-(4-aminobenzoyl)glycine Chemical compound NC1=CC=C(C(=O)NCC(O)=O)C=C1 HSMNQINEKMPTIC-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000005228 aryl sulfonate group Chemical group 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N benzyl-alpha-carboxylic acid Natural products OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- BFVNGHJRLLUPHY-UHFFFAOYSA-N bis(2-chloroethoxy)methylbenzene Chemical compound ClCCOC(OCCCl)C1=CC=CC=C1 BFVNGHJRLLUPHY-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003262 carboxylic acid ester group Chemical group [H]C([H])([*:2])OC(=O)C([H])([H])[*:1] 0.000 description 1
- 125000000271 carboxylic acid salt group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 150000003946 cyclohexylamines Chemical class 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940079360 enema for constipation Drugs 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- MUANZYIPCHDGJH-UHFFFAOYSA-N ethyl 2-(2-chlorophenyl)acetate Chemical compound CCOC(=O)CC1=CC=CC=C1Cl MUANZYIPCHDGJH-UHFFFAOYSA-N 0.000 description 1
- ZAOIIUSDMKVQJW-UHFFFAOYSA-N ethyl 2-chloropentanoate Chemical compound CCCC(Cl)C(=O)OCC ZAOIIUSDMKVQJW-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 150000002780 morpholines Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000002254 renal artery Anatomy 0.000 description 1
- 239000012262 resinous product Substances 0.000 description 1
- AWLUSOLTCFEHNE-UHFFFAOYSA-N sodium;urea Chemical compound [Na].NC(N)=O AWLUSOLTCFEHNE-UHFFFAOYSA-N 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical compound OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- HWCKGOZZJDHMNC-UHFFFAOYSA-M tetraethylammonium bromide Chemical compound [Br-].CC[N+](CC)(CC)CC HWCKGOZZJDHMNC-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000036325 urinary excretion Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/17—Unsaturated ethers containing halogen
- C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Description
Amino-trijodfenoksy-forbindelser med skyggegivende Amino-triiodophenoxy compounds with shading
virkning. effect.
Foreliggende oppfinnelse angår hittil ukjendte jodforbindelser, som kan anvendes som skyggegivende komponenter i røntgenkontrastmidler. The present invention relates to hitherto unknown iodine compounds, which can be used as shadowing components in X-ray contrast agents.
i in
- De hittil ukjente jodforbindelser med skyggegivende virkning er / 3-(N-alkylacylamino)-2,4,6-trijod-fenoksy_7-alkoksy-alkansyrer med den generelle formel I - The previously unknown iodine compounds with a shading effect are / 3-(N-alkylacylamino)-2,4,6-triiodo-phenoxy_7-alkoxy-alkanoic acids with the general formula I
hvor alkyl betyr en alkylgruppe med 1-4» fortrinnsvis 1-2 karbonatomer, where alkyl means an alkyl group with 1-4, preferably 1-2 carbon atoms,
acyl betyr en alkanoylgruppe med 2-4» fortrinnsvis 2, karbonatomer, alkylen betegner en alkylengruppe med 2-4 karbonatomer, og R betegner en alkylgruppe med 1-4 karbonatomer eller en fenylgruppe, samt deres metall- og aminsalter og deres estere med lavere alkoholer. acyl means an alkanoyl group with 2-4", preferably 2, carbon atoms, alkylene denotes an alkylene group with 2-4 carbon atoms, and R denotes an alkyl group with 1-4 carbon atoms or a phenyl group, as well as their metal and amine salts and their esters with lower alcohols .
Foretrukne skyggegivende amino-trijodfenoksyforbindelser er 2-(2'-/3"-(N-metyl(eller etyl)-acetylamino)-2",4"»6"-trijod-fenoksy_7-etoksy)-propion-eller smørsyre og disse syrers ikke-toksiske metall- eller aminsalter og deres estere med lavere alkoholer, da disse resorberes særlig godt fra det intestinale system, og blant disse foretrekkes spesielt 2-(2'-^3M<->(N-etyl-acetylamino)-2", 4",6"-trijod-fenoksv7-etoksy)-propionsyre og dens ikke-toksiske metall- eller aminsalter og dens estere med lavere alkoholer, da disse har gitt særdeles gode resultater ved den farmakologiske og kliniske prøvning, idet de viser en god tålbarhet og samtidig en høy bilitropisme, gir særdeles gode kontrastavbildninger av galdeorganene og har en vesentlig lavere nephrotoksisitet (påvirkning av nyrenes funksjonsdyktighet) enn de for tiden i overveiende grad anvendte orale galdekontrastmidler» Preferred shade-giving amino-triiodophenoxy compounds are 2-(2'-/3"-(N-methyl (or ethyl)-acetylamino)-2",4"»6"-triiodo-phenoxy_7-ethoxy)-propionic or butyric acid and these non-toxic metal or amine salts of acids and their esters with lower alcohols, as these are absorbed particularly well from the intestinal system, and among these 2-(2'-^3M<->(N-ethyl-acetylamino)-2 is particularly preferred ", 4",6"-triiodo-phenoxy(7-ethoxy)-propionic acid and its non-toxic metal or amine salts and its esters with lower alcohols, as these have given particularly good results in the pharmacological and clinical testing, showing a good tolerability and at the same time a high bilitropism, provides particularly good contrast images of the biliary organs and has a significantly lower nephrotoxicity (influence on the functioning of the kidneys) than the currently predominantly used oral bile contrast agents"
De omhandlede skyggegivende forbindelser er 3ærlig egnet for anvendelse til oral cholecystografio Ved passende formulering er de imidlertid f.eks. The shade-giving compounds in question are quite suitable for use in oral cholecystography. However, when formulated appropriately, they are e.g.
også anvendelige til røntgenfremstilling av kroppshulero also applicable for X-ray production of body cavities
Som det f„ekSo fremgår av øst-tysk patentskrift nr 19.923» vest-tysk patentskrift nr 1.179»336 og publikasjonene av Felder og Pitre, Il Farmaco 15, nr 6 (1960), side 609 - 631, og av Cassebaum, Die Pharmazie 1£, nr 6 (1960), As can be seen, for example, from East German Patent Document No. 19,923, West German Patent Document No. 1,179,336 and the publications by Felder and Pitre, Il Farmaco 15, No. 6 (1960), pages 609 - 631, and by Cassebaum, Die Pharmazie 1£, No. 6 (1960),
side 310 - 3l6, er anvendelsen av cx. -^3-acylamino-2,4» 6"-trijod-fenok8y7-alkan-syrer som skyggegivende bestanddeler i røntgenkontrastmidler gjentatte ganger blitt foreslått og mulighetene derfor inngående undersøkte Disse kjente forbindelser, som for de flestes vedkommende utskilles godt med urinen, er på den ene side for toksiske til en intravenøs anvendelse som røntgen-kontrastmidler og konsentreres på den annen side vanligvis i utilstrekkelig grad i galdeorganene, og de er derfor underlegne i forhold til de nu vanligvis anvendte cholecysto-grafimidlero Kun hos 2-(3-acetylamino-2,4,6-trijod-fenoksy)-kapronsyre er urin-utskillelsen mindre, og forbindelsens konsentrering i galden oppnår brukbare verdier» Ved den omfattende kliniske prøvning av dette stoff viste det seg imidlertid tydelig at den oppnådde kontrastvirkning er utilstrekkelig for mange formål <> pages 310 - 3l6, is the application of cx. -^3-acylamino-2,4»6"-triiodo-phenoxy-7-alkane acids as shadowing components in X-ray contrast agents have repeatedly been proposed and the possibilities therefore thoroughly investigated. These known compounds, which for the most part are excreted well with the urine, are on on the one hand too toxic for intravenous use as X-ray contrast agents and on the other hand are usually insufficiently concentrated in the bile organs, and they are therefore inferior to the currently commonly used cholecystography agents. Only in 2-(3-acetylamino- 2,4,6-triiodo-phenoxy)-caproic acid, the urinary excretion is less, and the concentration of the compound in the bile reaches usable values" In the extensive clinical testing of this substance, however, it became clear that the achieved contrast effect is insufficient for many purposes < >
Det samme gjelder for de lavere N-alkylerte 2,4»6-trijod-3-acylamino-fenoksy-alkankarboksylsyrer, som nylig er blitt kjent fra øst-tysk patent- The same applies to the lower N-alkylated 2,4»6-triiodo-3-acylamino-phenoxy-alkanecarboxylic acids, which have recently become known from East German patent
skrift nr 47°994°letter no 47°994°
Forbindelsene ifølge foreliggende oppfinnelse oppviser ikke disse ulemper. The compounds according to the present invention do not exhibit these disadvantages.
Nedenstående tabell I og II viser de for galdekontrastmidler av-gjørende egenskaper hos kontrastmiddelforbindelsene A, B, C, D, E og F ifølge oppfinnelsen sammenlignet med de tilsvarende egenskaper hos de i strukturell henseende nærmest beslektede, ved amid-nitrogenatomet ikke alkylerte forbindelser G og H, hos de ovenfor nevnte, i strukturell henseende sammenlignbare kjente forbindelser I, K og L, som hittil ikke har funnet noen praktisk anvendelse, og dessuten egenskapene hos to i praksis anvendte galdekontrastmidler M og N. Egenskapene er bestemt etter identiske metoder og under identiske ytre betingelser. Tables I and II below show the decisive properties for bile contrast agents of the contrast agent compounds A, B, C, D, E and F according to the invention compared to the corresponding properties of the structurally most closely related compounds G and H, in the above-mentioned structurally comparable known compounds I, K and L, which have so far not found any practical application, and also the properties of two practically used bile contrast agents M and N. The properties have been determined according to identical methods and under identical external conditions.
A: 2-(2'-/~3"-(N-etyl-acetylamino)-2",1",6"-trijod-fenoksv7-etoksy)-propionsyre. A: 2-(2'-[3"-(N-ethyl-acetylamino)-2",1",6"-triiodo-phenoxy-ethoxy)-propionic acid.
B: 2-(2,-/~3"-(N-metyl-propionylamino)-2",<i>+",6"-trijod-fenoksY7-et oksy)-prop ionsyre. B: 2-(2,-/~3"-(N-methyl-propionylamino)-2",<i>+",6"-triiodo-phenoxyY7-etoxy)-propionic acid.
C: 2- (2'-/~3"-(N-metyl-acetylamino)-2",4",6"-trijod-fenoksv?-etoksy)-smørsyre. C: 2-(2'-[3"-(N-methyl-acetylamino)-2",4",6"-triiodo-phenoxy-ethoxy)-butyric acid.
D: 2-(2'-/3"-(H-etyl-acetylamino)-2",M-",6"-trijod-fenoksY7-etoksy)-smørsyre. D: 2-(2'-[3"-(H-ethyl-acetylamino)-2",M-",6"-triiodo-phenoxy-7-ethoxy)-butyric acid.
E: 2-(2'-/3"-(N-metyl-acetylamino)-2",4",6"-trijod-fenoksy?-etoksy)-fenyleddiksyre E: 2-(2'-/3"-(N-methyl-acetylamino)-2",4",6"-triiodo-phenoxy?-ethoxy)-phenylacetic acid
F: 2-(2'-/3"-(N-etyl-acetylamino)-2",4",6"-trijod-fenoksy/-etoksy)-fenyleddiksyre. F: 2-(2'-[3"-(N-ethyl-acetylamino)-2",4",6"-triiodo-phenoxy/-ethoxy)-phenylacetic acid.
G: 2-/2<*->(3"-acetylamino-2",4",6"-trijod-<f>enoksy)-etoksv7-propionsyre. H: 2-/2,-(3"-acétylamino-2",4",6"-trijod-fenoksy)-etoksY7-fenyleddiksyre. G: 2-(2<*->(3"-acetylamino-2",4",6"-triiodo-<f>enoxy)-ethoxys7-propionic acid). H: 2-[2,-(3"-acetylamino-2",4",6"-triiodo-phenoxy)-ethoxy]7-phenylacetic acid.
I: »-/3-(N-metyl-acetylamino)-2,4,6-trijod-fenoksv7-eddiksyre, I: -/3-(N-methyl-acetylamino)-2,4,6-triiodo-phenoxy-acetic acid,
øst-tysk patentskrift nr. 47.994. East German Patent Document No. 47,994.
K: *-(3-acetylamino-2,4,6-trijod-fenoksy)-smørsyre, K: *-(3-acetylamino-2,4,6-triiodo-phenoxy)-butyric acid,
øst-tysk patentskrift nr. 19.923. East German Patent Document No. 19,923.
L: «- (3-acetylamino-2,4,6-trijod-fenoksy)-kapronsyre, L: «-(3-acetylamino-2,4,6-triiodo-phenoxy)-caproic acid,
vest-tysk patentskrift nr. 1.179.336. West German Patent Document No. 1,179,336.
H: *-etyl-p-(3-hydroksy-2,4,6-trijod-fenyl)-propionsyre, H: *-ethyl-p-(3-hydroxy-2,4,6-triiodo-phenyl)-propionic acid,
/ Acidum Iophenoicunj/. / Acidum Iophenoicunj/.
N: £-/3-dimetylamino-metylen-amino)-2,4,6-trijodfenyl7-propionsyre, N: ((3-dimethylamino-methylene-amino)-2,4,6-triiodophenyl-7-propionic acid,
/ Iopodate/. / Iopodate/.
Av denne tabell I fremgår: This table I shows:
a) Tålbarheten av de her omhandlede røntgenkontrastmiddelforbindelser er fullt ut tilstrekkelig til en risikofri peroral anvendelse. b) Galdeutskillelsesverdiene og utskillelsesforholdene galde/urin er for forbindelsene ifølge oppfinnelsen ca. lo ganger så gunstige som for de i a) The tolerability of the X-ray contrast agent compounds referred to here is fully sufficient for risk-free oral use. b) The bile excretion values and excretion ratios bile/urine for the compounds according to the invention are approx. lo times as favorable as for those in
strukturell henseende nærmest beslektede, ved araidnitrogenatomet ikke alkylerte forbindelser G og H og for de i strukturell henseende sammenlignbare kjente forbindelser I, K og L. Bilitropismen av forbindelsene A - F er da også meget mer utpreget enn ved de i praksis anvendte, men i konstitusjonell henseende ikke sammenlignbare, galdekontrastmidler M og N. structurally most closely related compounds G and H, not alkylated at the araide nitrogen atom, and for the structurally comparable known compounds I, K and L. The bilitropism of compounds A - F is then also much more pronounced than with those used in practice, but in constitutional regarding not comparable, bile contrast agents M and N.
Med forbindelsene A, B, C, D, E og F ifølge oppfinnelsen oppnås etter peroral administrering vanligvis utmerkede kontrastavbildninger av galdeorganene, jfr. tabell II, som viser resultater av cholecystografier (gjennomsnittsverdi av 2 - 1 enkeltforsøk). With the compounds A, B, C, D, E and F according to the invention, excellent contrast images of the biliary organs are usually obtained after oral administration, cf. table II, showing results of cholecystographies (average value of 2 - 1 individual attempts).
Med forbindelsen F er det ved katteforsøk etter peroral administrering oppnådd særdeles gode avbildninger av galdeveiene, hvilke vanligvis kun oppnås med intravenøst administrerbare cholecystografimidler. With compound F, particularly good images of the bile ducts have been obtained in cat experiments after oral administration, which are usually only obtained with intravenously administered cholecystography agents.
Forbindelsen A er allerede blitt underkastet meget inngående farmakologiske og kliniske detaljundersøkelser: I forhold til jodpanosyre («-etyl-p-(3-amino-2,4,6-trijod-fenyl)-propionsyre) - et hyppig anvendt oralt galdekontrastmiddel - viste forbindelse A seg i dobbeltblindforsøk overlegen med hensyn til kvaliteten av galdeorganavbildningen. Tarmrester, som reduserer avbildningskvaliteten, forekom ikke. Compound A has already been subjected to very thorough pharmacological and clinical detailed investigations: In relation to iodopanoic acid («-ethyl-p-(3-amino-2,4,6-triiodo-phenyl)-propionic acid) - a frequently used oral bile contrast agent - showed compound A was superior in double-blind trials with regard to the quality of biliary organ imaging. Intestinal remnants, which reduce imaging quality, did not occur.
Forbindelsen A oppviser også en meget lavere nephrotoksisitet enn jodopanosyre. Kontrastmidlers innflytelse på nyrenes funksjonsdyktighet ble målt ved forminskelsen av nyrenes utskillelsesevne for paraaminohippursyre Compound A also exhibits a much lower nephrotoxicity than iodopanic acid. The influence of contrast agents on the functioning of the kidneys was measured by the reduction of the kidneys' ability to excrete para-aminohippuric acid
(PAH) - etter subkutan administrering av 2oo mg/kg - og kreatinin - etter subkutan administrering av 5o ml 5% oppløsning. 1 time etter injeksjon av 1 ml kontrastmiddel-natriumsaltoppløsning direkte i den venstre nyrearterie i bedøvede kaniner ble clearance-funksjonen av begge nyrer sammenlignet (den venstre behandlet med kontrastmiddel, den høyre ubehandlet). Resultatene er vist i tabell III, som angir gjennomsnittsverdier av fem forsøk. (PAH) - after subcutaneous administration of 2oo mg/kg - and creatinine - after subcutaneous administration of 5o ml of 5% solution. 1 hour after injection of 1 ml of contrast medium-sodium salt solution directly into the left renal artery in anesthetized rabbits, the clearance function of both kidneys was compared (the left treated with contrast medium, the right untreated). The results are shown in Table III, which indicates average values of five trials.
Av tabell III fremgår at forbindelsen A tåles meget bedre enn jodopanosyre. Jodopanosyre nedsetter - i motsetning til forbindelse A - clearance-funksjonen av nyrene, selv ved lave konsentrasjoner. Table III shows that compound A is much better tolerated than iodopanic acid. Iodopanic acid reduces - in contrast to compound A - the clearance function of the kidneys, even at low concentrations.
Denne forbindelse har også i mennesker vist seg å være et særlig godt oralt galdekontrastmiddel: Med en dose på 3 g av forbindelsen A er det i 5 av 8 tilfelle (5 kvinner og 3 menn) oppnådd særdeles gode og i 2 tilfelle fremragende kontrastavbildnihger av galdeveiene. This compound has also proven to be a particularly good oral biliary contrast agent in humans: With a dose of 3 g of compound A, in 5 out of 8 cases (5 women and 3 men) very good and in 2 cases excellent contrast images of the biliary tract were obtained .
De omhandlede hittil ukjente forbindelser kan anvendes som frie syrer eller i form av sine ikke-toksiske metall- og aminsalter eller sine estere. Som metall-salter kan f.eks. anvendes natrium-, litium-, kalsium-, og magnesiumsalterj som aminsalter kan fortrinnsvis anvendes N-metylglukamin-, dietanolamin- og morfolin-salter. The previously unknown compounds in question can be used as free acids or in the form of their non-toxic metal and amine salts or their esters. As metal salts, e.g. sodium, lithium, calcium and magnesium salts are used as amine salts, N-methylglucamine, diethanolamine and morpholine salts can preferably be used.
Forbindelsene ifølge oppfinnelsen kan fremstilles på forskjellige måter. Således kan man The compounds according to the invention can be prepared in different ways. Thus one can
a) alkylere en (3-acylamino-2,4,6-trijod-fenoksy)-alkoksy-alkansyre med den generelle formel III a) alkylating a (3-acylamino-2,4,6-triiodo-phenoxy)-alkoxy-alkanoic acid of the general formula III
hvor acyl betegner en alkanoylgruppe med 2-4, fortrinnsvis 2, karbonatomer, alkylen betegner en alkylengruppe med 2-4 karbonatomer, og R betegner en alkylgruppe med 1-4 karbonatomer eller en fenylgruppe, ved nitrogenatomet, eller b) i nærvær av basiske kondensasjonsmidler omsette en 3-(N-alkyl-acylamino)-2,4,6-trijod-fenol med den generelle formel IV hvor alkyl betegner en alkylgruppe med 1-4, fortrinnsvis 1-2, karbonatomer, og acyl betegner en . alkanoylgruppe med 2-4, fortrinnsvis 2, karbonatomer, med et reaktivt alkoksyalkansyrederivat med den generelle formel V where acyl denotes an alkanoyl group with 2-4, preferably 2, carbon atoms, alkylene denotes an alkylene group with 2-4 carbon atoms, and R denotes an alkyl group with 1-4 carbon atoms or a phenyl group, at the nitrogen atom, or b) in the presence of basic condensing agents react a 3-(N-alkyl-acylamino)-2,4,6-triiodo-phenol with the general formula IV where alkyl denotes an alkyl group with 1-4, preferably 1-2, carbon atoms, and acyl denotes a . alkanoyl group with 2-4, preferably 2, carbon atoms, with a reactive alkoxyalkanoic acid derivative of the general formula V
hvor X betegner en reaktiv rest av en sterk syre, og -COOR' betegner en karboksyl- where X denotes a reactive residue of a strong acid, and -COOR' denotes a carboxyl-
syreestergruppe eller en karboksylsyresaltgruppe, mens alkylen og R har den under acid ester group or a carboxylic acid salt group, while the alkylene and R have it below
a) angitte betydning, og eventuelt deretter forsåpe karboksylsyreestergruppen. a) indicated meaning, and optionally then saponify the carboxylic acid ester group.
Den reaktive rest X av en sterk syre består fortrinnsvis av et halogenatom The reactive residue X of a strong acid preferably consists of a halogen atom
såsom klor, brom og jod, eller en sulfat- eller en sulfonatrest, f.eks. en alkyl-eller aryl-sulfonatrest (R-S020-). such as chlorine, bromine and iodine, or a sulfate or a sulfonate residue, e.g. an alkyl or aryl sulfonate residue (R-SO 2 O-).
Man kan således fremstille de omhandlede skyggegivende / 3-(N-alkyl-acylaroino)-2,4,6-trijod-fenoksy_7-alkoksy-alkansyrer ved at man i alkalisk miljø omsetter en (3-acylamino-2,4,6-trijod-fenoksy)-alkoksy-alkansyre med en reaktiv alkylester av en sterk syre, særlig med et alkylhalogenid, -sulfat eller -sulfonat. One can thus prepare the mentioned shade-giving / 3-(N-alkyl-acylaroino)-2,4,6-triiodo-phenoxy_7-alkoxy-alkanoic acids by reacting in an alkaline environment a (3-acylamino-2,4,6- triiodo-phenoxy)-alkoxy-alkanoic acid with a reactive alkyl ester of a strong acid, in particular with an alkyl halide, sulfate or sulfonate.
De ønskede forbindelser kan imidlertid også fremstilles ved at man i nærvær av et alkalimetallalkoholat eller alkalimetallkarbonat kondenserer en 3-(N-alkyl-acylamino)-2,t,6-trijod-fenol med en halogenalkoksyalkansyreester og eventuelt deretter forsåper estergruppen. However, the desired compounds can also be prepared by condensing a 3-(N-alkyl-acylamino)-2,t,6-triiodo-phenol with a haloalkoxyalkanoic acid ester in the presence of an alkali metal alcoholate or alkali metal carbonate and optionally then saponifying the ester group.
Fremstillingen av og egenskapene for disse hittil ukjendte skyggegivende forbindelser ifølge oppfinnelsen fremgår av nedenstående eksmpler. The production of and the properties of these hitherto unknown shade-giving compounds according to the invention can be seen from the examples below.
Eksempel 1 Example 1
2-( 2'-/" 3"-( N- Etvl- acetvlamino)- 2", 4", 6"- trijod- fenoksy 7- etoks^- propionsyre 2-( 2'-/" 3"-( N-Etvl-acetvlamino)- 2", 4", 6"- triiodo-phenoxy 7- ethoxy^- propionic acid
Til 17,85 g 2-/~2l<->(3"-acetylamino-2",4",6"-trijod-fenoksy)-etoksy_7-propionsyre (o,o28 mol), oppløst i 3o ml 4N vandig kaliumhydroksydoppløsning (o,12 mol), settes under omrøring ved 3o 35°C dråpevis i løpet av 2o minutter 6,5 g etyljodid (o,o42 mol) i 3 ml aceton. Det omrøres videre i 4 timer ved 4o°C, hvoretter det fortynnes med 2oo ml vann, og den resulterende oppløsning avfarves ved tilsetning av en liten mengde NaHSO„, hvoretter produktet utfelles ved tilsetning av konsentrert saltsyre. Den klebrige felning skilles fra den vandige fase ved ekstraksjon med etylacetat. Ekstrakten vaskes med vann, avfarves med aktivt kull og inndampes til tørrhet, hvoretter det snart inntrer krystallisasjon, Den på denne måte erholdte 2-(2,-/~3"-(N-etyl-acetylaniino)-2",4",6"-trijod-fenoksy_7-etoksy)-propionsyre (15,8 g) smelter etter 2 omkrystalliseringer fra 5o%'s etanol, ved 15o - 151°C. To 17.85 g of 2-/~2l<->(3"-acetylamino-2",4",6"-triiodo-phenoxy)-ethoxy_7-propionic acid (0.028 mol), dissolved in 30 ml of 4N aqueous potassium hydroxide solution (0.12 mol), add 6.5 g of ethyl iodide (0.042 mol) in 3 ml of acetone dropwise over 20 minutes while stirring at 3o 35°C. It is further stirred for 4 hours at 4o°C, after which it is diluted with 2oo ml of water, and the resulting solution is decoloured by the addition of a small amount of NaHSO„, after which the product is precipitated by the addition of concentrated hydrochloric acid. The sticky precipitate is separated from the aqueous phase by extraction with ethyl acetate. The extract is washed with water, decolorized with activated charcoal and evaporated to dryness, after which crystallization soon occurs. The thus obtained 2-(2,-/~3"-(N-ethyl-acetylaniino)-2",4", 6"-triiodo-phenoxy_7-ethoxy)-propionic acid (15.8 g) melts after 2 recrystallizations from 50% ethanol, at 150-151°C.
Analyse:beregnet for C^,.H^<gJg>NO,. Analysis: calculated for C^,.H^<gJg>NO,.
Ekvivalentvekt: beregnet: 673,06, funnet: 676. Equivalent weight: calculated: 673.06, found: 676.
C: beregnet: 26,76%, funnet: 26,85% C: calculated: 26.76%, found: 26.85%
J: beregnet: 56,57%, funnet: 56,65% J: calculated: 56.57%, found: 56.65%
Tynnskiktskromatogram: Medium: Silikagel "GF 254" (Merck) Thin layer chromatogram: Medium: Silica gel "GF 254" (Merck)
Utviklingsmiddel: Klorofonn/iseddik i forholdet 19:1 Rp-verdi: o,32 Developer: Chlorophon/glacial vinegar in the ratio 19:1 Rp value: o.32
Oppløseligheter: Forbindelsen er uoppløselig i vann, i liten grad oppløselig Solubilities: The compound is insoluble in water, slightly soluble
i kald metanol og etanol, moderat oppløselig i kald kloroform, in cold methanol and ethanol, moderately soluble in cold chloroform,
særdeles lett oppløselig i kokende metanol, etanol og kloroform. Natrium- og N-metylglukaminsalt: i* loo g/loo ml vandig oppløsning ved 2o°C extremely easily soluble in boiling methanol, ethanol and chloroform. Sodium and N-methylglucamine salt: i* loo g/loo ml aqueous solution at 2o°C
Den som utgangsstoff anvendte 2-/~2,-(3,,-acetylamino-2",4",6"-trijod-fenoksy)-etoksy_7-propionsyre fremstilles på følgende måte: The 2-/~2,-(3,,-acetylamino-2",4",6"-triiodo-phenoxy)-ethoxy_7-propionic acid used as starting material is prepared in the following way:
a) 2-(2<1->kloretoksy)-propionsyre-etylester. a) 2-(2<1->chloroethoxy)-propionic acid ethyl ester.
Denne forbindelse fremstilles av 3o g 2-(2'-kloretoksy)-propionitril i 3o ml etanol This compound is prepared from 30 g of 2-(2'-chloroethoxy)-propionitrile in 30 ml of ethanol
ved 2 timers tilførsel av HCl-gass, innrøring av det på denne måte dannede iminoeter-hydroklorid i 2oo g knust is og ekstraksjon av det på denne måte dannede produkt med dietyleter. Kokepunktet er 96 - loo°C/12 - 14 mm Hg. Utbyttet er 23,8 g (57,5%). b) 2-/2,-(3"-Acetylamino-2ll,4,,,6"-trijod-fenoksy)-etoksy_7-propionsyre-ety lester. by supplying HCl gas for 2 hours, stirring the imino ether hydrochloride formed in this way into 200 g of crushed ice and extracting the product formed in this way with diethyl ether. The boiling point is 96 - loo°C/12 - 14 mm Hg. The yield is 23.8 g (57.5%). b) 2-[2,-(3"-Acetylamino-211,4,,6"-triiodo-phenoxy)-ethoxy-7-propionic acid ethyl ester.
Denne forbindelse fåes ved omsetning av 14,7 g 3-acetylamino-2,4,6-trijod-fenol This compound is obtained by reacting 14.7 g of 3-acetylamino-2,4,6-triiodo-phenol
med 5,6 g 2-(2'-kloretoksy)-propionsyre-etylester i nærvær av o,o37 mol natriumetylat i ca. 2o ml etanol ved 4o timers kokning. Utbyttet er 11 g, smeltepunktet (etter omkrystallisering fra etanol) er 148 - 151°C. with 5.6 g of 2-(2'-chloroethoxy)-propionic acid ethyl ester in the presence of o.o37 mol sodium ethylate in approx. 2o ml of ethanol at 4o hours of boiling. The yield is 11 g, the melting point (after recrystallization from ethanol) is 148 - 151°C.
c) 2-/2<1->(3"-Acetylamino-2",4",6"-trijod-fenoksy)-etoksv7- propionsyre. Denne forbindelse fåes ved forsåpning av 6,1 g av etylesteren med o,5 g natriumhydroksyd i 3o ml metanol og i alt 12o ml vann og etterfølgende surgjøring av natriumsaltoppløsningen. Utbyttet er 4,95 g (85%), smeltepunktet er 173 - 175°C. Eksempel 2 c) 2-[2<1->(3"-Acetylamino-2",4",6"-triiodo-phenoxy)-ethoxy-7-propionic acid. This compound is obtained by saponification of 6.1 g of the ethyl ester with 0.5 g of sodium hydroxide in 30 ml of methanol and a total of 120 ml of water and subsequent acidification of the sodium salt solution. The yield is 4.95 g (85%), the melting point is 173 - 175°C. Example 2
2-(2,-/3"-(N-Etyl-propionylamino)-2",4",6"-trijod-fenoksy_7-etoksy)-propionsyre. 2-(2,-/3"-(N-Ethyl-propionylamino)-2",4",6"-triiodo-phenoxy_7-ethoxy)-propionic acid.
Til 6,6 g 2-/2,-(3"-propionylamino-2",4",6"-trijod-fenoksy)-etoksy_7-propionsyre (o,ol mol), oppløst i 12 ml vann i 3,33N kaliumhydroksydoppløsning (o,o4 mol), settes under omrøring 2,35 g etyljodid oppløst i 1,5 ml aceton. Det omrøres i ytterligere 3 timer ved 4o°C. To 6.6 g of 2-[2,-(3"-propionylamino-2",4,6"-triiodo-phenoxy)-ethoxy_7-propionic acid (0.01 mol), dissolved in 12 ml of water at 3.33N potassium hydroxide solution (0.04 mol), add, while stirring, 2.35 g of ethyl iodide dissolved in 1.5 ml of acetone. It is stirred for a further 3 hours at 4o°C.
Isoleringen av det ved nitrogenatomet etylerte produkt skjer ved fortynning av reaksjonsoppløsningen med 5o ml vann, ekstraksjon av nøytrale stoffer med etyleter og surgjøring av den vandige fase med 18%'s saltsyre, hvorved det dannes en klebrig feining, som opptas i etylacetat, vaskes med vann og befries for oppløsnings-middel ved inndampning. The isolation of the product ethylated at the nitrogen atom takes place by diluting the reaction solution with 50 ml of water, extracting neutral substances with ethyl ether and acidifying the aqueous phase with 18% hydrochloric acid, whereby a sticky fine is formed, which is taken up in ethyl acetate, washed with water and freed from solvent by evaporation.
Inndampningsresidu et opptas i en liten mengde frisk kokende etylacetat (5 ml) og holdes i 3o minutter ved dette oppløsningsmiddels kokepunkt, hvoretter 2-(2'-/3"-(N-etyl-propionylamino)-2",4",6"-trijod-fenoksy_7-etoksy)-propionsyre litt etter litt krystalliserer. The evaporation residue is taken up in a small amount of fresh boiling ethyl acetate (5 ml) and held for 30 minutes at the boiling point of this solvent, after which 2-(2'-/3"-(N-ethyl-propionylamino)-2",4",6 "-triiodo-phenoxy_7-ethoxy)-propionic acid little by little crystallizes.
Smeltepunktet er lo5 - lo6°C. The melting point is lo5 - lo6°C.
Analyse: beregnet for C,CH- J„NOc Analysis: calculated for C,CH- J„NOc
lo 2o 3 5 lo 2o 3 5
Ekvivalentvekt: beregnet-; 687,06, funnet: 686 Equivalent weight: calculated-; 687.06, found: 686
C: beregnet: 27,97%, funnet 27,83% C: calculated: 27.97%, found 27.83%
■J: beregnat: 55,42?,, funnet S5,26% ■J: calculated: 55.42?,, found S5.26%
Tynnskiktskromatogram: Medium: Silikagel "GF 254" Thin layer chromatogram: Medium: Silica gel "GF 254"
Utviklingsmiddel: Benzen/kloroform/iseddik i forholdet 7:3:2 Developer: Benzene/chloroform/glacial vinegar in the ratio 7:3:2
RF-verdi: °t<65>RF value: °t<65>
Oppløseligheter: Stoffet er uoppløselig i vann, men lett oppløselig i lavere Solubilities: The substance is insoluble in water, but easily soluble in lower
alkoholer og kloroform. alcohols and chloroform.
Den som utgangsstoff anvendte 2-/2'-(3"-propionylamino-2",4",6"-trijod-fenoksy)-etoksy_/-propionsyre fåes ved omsetning av 86,6 g 3-propionylamino-2,4,6-trijod- The 2-/2'-(3"-propionylamino-2",4",6"-triiodo-phenoxy)-ethoxy-/-propionic acid used as starting material is obtained by reacting 86.6 g of 3-propionylamino-2,4, 6-triiodo-
fenol med 32,8 g 2-(2-kloretoksy)-propionsyre-etylester i nærvær av o,176 mol natriumetylat i 14o ml etanol ved 4o timers kokning under tilbakeløpkjøling og etterfølgende forsåpning av den erholdte 2-/2,-(3"-propionylamino-2",4',,6"-trijodfenoksy)-etoksy_7-propionsyre-etylester (45,9 g, smeltepunkt 129 - 13o°C, Rp-verdi: o,6o (på silikagel med benzen/kloroform/iseddik i forholdet 7:3:2)) med 3,2 g natriumhydroksyd i 2oo ml etanol og 5o ml vann ved 1 times kokning under tilbake-løpskjøling, fortynning av reaksjonsoppløsningen med 5oo ml vann og etterfølgende surgjøring av natriumsaltoppløsningen. Utbyttet er (etter omkrystallisering fra etanol) 37,5 g (85% av det teoretiske), smeltepunkt 149 - 151°C. Rp-verdi: o,33 phenol with 32.8 g of 2-(2-chloroethoxy)-propionic acid ethyl ester in the presence of o.176 mol of sodium ethylate in 14o ml of ethanol by boiling for 4o hours under reflux and subsequent saponification of the obtained 2-/2,-(3" -propionylamino-2",4',,6"-triiodophenoxy)-ethoxy_7-propionic acid ethyl ester (45.9 g, melting point 129 - 13o°C, Rp value: o.6o (on silica gel with benzene/chloroform/glacial acetic in the ratio 7:3:2)) with 3.2 g of sodium hydroxide in 200 ml of ethanol and 50 ml of water by boiling for 1 hour under reflux, diluting the reaction solution with 500 ml of water and subsequently acidifying the sodium salt solution. The yield is (after recrystallization from ethanol) 37.5 g (85% of theoretical), melting point 149 - 151°C. Rp value: o.33
(på silikagel under anvendelse av etylacetat/isopropanol/ammoniakk i forholdet 55:35:2o). (on silica gel using ethyl acetate/isopropanol/ammonia in the ratio 55:35:2o).
Eksempel 3 Example 3
2-(2'-/3"-(N-Metyl-propionylamino)-2",4",6"-trijod-fenoksy_7-etoksy)-propionsyre. 2-(2'-[3"-(N-Methyl-propionylamino)-2",4",6"-triiodo-phenoxy_7-ethoxy)-propionic acid.
Til 19,8 g 2-/2l<->(3"-propionylamino-2",4",6"-trijod-fenoksy)-etoksy_7-propionsyre (o,o3 mol) i 35 ml vann inneholdende 7,9 g 85%'s kaliumhydroksyd-oppløsning (o,12 mol) dryppes en oppløsning av 6,4 metyljodid i 3 ml aceton. Reaksjonsoppløsningen omrøres i 3 timer ved 4o°C. To 19.8 g of 2-[2l<->(3"-propionylamino-2",4",6"-triiodo-phenoxy)-ethoxy_7-propionic acid (0.03 mol) in 35 ml of water containing 7.9 g A solution of 6.4 methyl iodide in 3 ml of acetone is added dropwise to the 85% potassium hydroxide solution (0.12 mol). The reaction solution is stirred for 3 hours at 4o°C.
Isoleringen av det erholdte, ved nitrogenatomet metylerte produkt skjer The isolation of the product obtained, methylated at the nitrogen atom, takes place
etter den i eksempel 2 beskrevne metode. according to the method described in example 2.
Det rå, ennu harpiksaktige produkt opptas i 15 ml etylacetat. Litt etter The crude, still resinous product is taken up in 15 ml of ethyl acetate. Just after
litt utkrystalliserer den ønskede 2-(2 W3H-(N-metyl-propionylamino)-2",4",6',-trijod-fenoksy_7-etoksy )-propionsyre i ren form. slightly crystallizes out the desired 2-(2W3H-(N-methyl-propionylamino)-2",4",6',-triiodo-phenoxy_7-ethoxy)-propionic acid in pure form.
Utbyttet er 12,4 g (61,6% av det teoretiske). The yield is 12.4 g (61.6% of the theoretical).
Smeltepunkt: 113 - 115°C. Melting point: 113 - 115°C.
Analyse: beregnet for C^H^gJgNOg Analysis: calculated for C^H^gJgNOg
Ekvivalentvekt: beregnet: 673,06, funnet: 669. Equivalent weight: calculated: 673.06, found: 669.
C: beregnet: 26,77%, funnet: 26,84% C: calculated: 26.77%, found: 26.84%
J: beregnet: 56,57%, funnet: 56,4o% J: calculated: 56.57%, found: 56.4o%
Tynnskiktskromatogram: Medium: Silikagel "GF 254" Thin layer chromatogram: Medium: Silica gel "GF 254"
Utviklingsmiddel: Benzen/kloroform/iseddik i forholdet 7:3:2. Developer: Benzene/chloroform/glacial vinegar in the ratio 7:3:2.
Rp-verdi: o,53 Rp value: o.53
Oppløseligheter: Stoffet er praktisk talt uoppløselig i vann, men særdeles lett Solubilities: The substance is practically insoluble in water, but extremely light
oppløselig i metanol, etanol og kloroform. soluble in methanol, ethanol and chloroform.
Natrium- og N-metylglukaminsaltet er begge særdeles lett opp-løselige i vann (XLoo g/loo ml oppløsning ved 2o°C). The sodium and N-methylglucamine salt are both extremely easily soluble in water (XLoo g/loo ml solution at 2o°C).
Eksempel 4 Example 4
2-(2,-/3"-(N-Etyl-acetylamino)-2",l+",6"-trijod-fenoksy_7-etoksy)-smørsyre. 2-(2,-/3"-(N-Ethyl-acetylamino)-2",1+",6"-triiodo-phenoxy_7-ethoxy)-butyric acid.
Til 5,5 g 2-/2'-(3"-acetylamino-2",4",6"-trijod-fenoksy)-etoksy_7- smørsyre (o,oo84 mol), oppløst i 8 ml 4N kaliumhydroksydoppløsning (o.o32 mol), settes 2 g etyljodid (o,ol25 mol) oppløst i 1 ml aceton. Den resulterende blanding omrøres i 4 timer ved 4o°C. To 5.5 g of 2-/2'-(3"-acetylamino-2",4",6"-triiodo-phenoxy)-ethoxy_7-butyric acid (0.oo84 mol), dissolved in 8 ml of 4N potassium hydroxide solution (o. o32 mol), add 2 g of ethyl iodide (o.ol25 mol) dissolved in 1 ml of acetone. The resulting mixture is stirred for 4 hours at 40°C.
Isoleringen av det N-etylerte produkt skjer etter den i eksempel 1 beskrevne metode. The isolation of the N-ethylated product takes place according to the method described in example 1.
Utbytte: 4,5 g. Yield: 4.5 g.
Etter omkrystallisering av en liten mengde etylacetat smelter denne hittil ukjendte forbindelse ved 131°C. After recrystallization from a small amount of ethyl acetate, this hitherto unknown compound melts at 131°C.
Analyse: beregnet for C^ H^ JJ^ O^ Analysis: calculated for C^ H^ JJ^ O^
Ekvivalentvekt: beregnet: 687,06, funnet: 69o. Equivalent weight: calculated: 687.06, found: 69o.
C: beregnet: 27,97%, funnet: 28,o8%. C: calculated: 27.97%, found: 28.o8%.
J: beregnet: 55,42%, funnet: 55,6o%. J: calculated: 55.42%, found: 55.6o%.
Tynnskiktskromatogram: Medium: Silikagel "GF 254" Thin layer chromatogram: Medium: Silica gel "GF 254"
Utviklingsmiddel: Kloroform/iseddik i forholdet 19:1. Developer: Chloroform/glacial vinegar in a ratio of 19:1.
Rp-verdi: o,41 Rp value: o.41
Oppløseligheter: Stoffet er uoppløselig i vann, men lett oppløselig i lavere alkoholer og i kloroform. Solubilities: The substance is insoluble in water, but easily soluble in lower alcohols and in chloroform.
Natrium- og N-metylglukaminsalt:^loog/loo ml vandig oppløsning Sodium and N-methylglucamine salt: ^loog/loo ml aqueous solution
ved 2o°C. at 2o°C.
Den som utgangsstoff anvendte 2-/2,-(3"-acetylamino-2",4",6"-trijod-fenoksy)-etoksy_7- smørsyre fremstilles på følgende måte: The 2-/2,-(3"-acetylamino-2",4",6"-triiodo-phenoxy)-ethoxy-7-butyric acid used as starting material is prepared in the following way:
a) 8,5 g 2-(2<1->kloretoksy)-butyronitril (Lingo, J. Amer. chem. Soc. 61, a) 8.5 g of 2-(2<1->chloroethoxy)-butyronitrile (Lingo, J. Amer. chem. Soc. 61,
1574 (1939)) oppløst i 15 ml etanol behandles i 2 timer med gassformig hydrogen-klorid og kokes deretter i 4 timer under tilbakeløpskjøling. Det på denne måte erholdte iminoeter-hydroklorid med formelen . 1574 (1939)) dissolved in 15 ml of ethanol is treated for 2 hours with gaseous hydrogen chloride and then boiled for 4 hours under reflux. The imino ether hydrochloride obtained in this way has the formula .
Cl-CH/,-CHo-0-CH(C.H(.)-C(0C-Hc.) = NH.HC1 Cl-CH/,-CHo-0-CH(C.H(.)-C(OC-Hc.) = NH.HC1
forsåpes med isvann, hvorved det fåes 2-(2'-kloretoksy)-smørsyre-etylester. Kokepunktet er lo4 - lo8°C/12 mm Hg, utbyttet er 5,25 g (45%), nD = l,44oo. saponified with ice water, whereby 2-(2'-chloroethoxy)-butyric acid ethyl ester is obtained. The boiling point is lo4 - lo8°C/12 mm Hg, the yield is 5.25 g (45%), nD = 1.44oo.
b) 12,6 g 3-acetylamino-2,4,6-trijod-fenol omsettes i nærvær av o,o26 mol natriuraetylat i ca. 2o ml etanol med 5 g 2-(2'-kloretoksy)-smørsyre-etylester ved 24 timers kokning, hvorved det dannes 2-/2'-(3"-acetylamino-2",4",6"-trijod-fenoksy)-etoksy_7- smørsyre-etylester. Utbyttet er 7,5 g, smeltepunkt (etter omkrystallisering fra etanol): 12o°C. R^-verdi: o,41 (på silikagel med kloroform/iseddik i forholdet 19:1). c) 2-/21-(3"-Acetylamino-2",4",6"-trijod-fenoksy)-etoksy_7-smørsyre fås ved forsåpning av den under b) erholdte etylester (1,5 g) med 3,5 ml IN natrium-hydroksydoppløsning i 8 ml metanol og 24 ml vann ved 1 times kokning og påfølgende surgjøring av natriumsaltoppløsningen. Utbyttet er 1,1 g (89% av det teoretiske), smeltepunkt (etter omkrystallisering fra 5o%'s etanol): 163 - 165°C. R^-verdien er o,195 (på silikagel med kloroform/iseddik i forholdet 19:1). b) 12.6 g of 3-acetylamino-2,4,6-triiodo-phenol is reacted in the presence of o.o26 mol of sodium urea ethylate for approx. 20 ml of ethanol with 5 g of 2-(2'-chloroethoxy)-butyric acid ethyl ester at 24 hours of boiling, whereby 2-/2'-(3"-acetylamino-2",4",6"-triiodo-phenoxy is formed )-ethoxy_7- butyric acid ethyl ester. The yield is 7.5 g, melting point (after recrystallization from ethanol): 12o°C. R^ value: o.41 (on silica gel with chloroform/glacial acetic acid in a ratio of 19:1). c) 2-/21-(3"-Acetylamino-2",4",6"-triiodo-phenoxy)-ethoxy_7-butyric acid is obtained by saponification of the ethyl ester obtained under b) (1.5 g) with 3.5 ml IN sodium hydroxide solution in 8 ml methanol and 24 ml water by boiling for 1 hour and subsequent acidification of the sodium salt solution. The yield is 1.1 g (89% of the theoretical), melting point (after recrystallization from 50% ethanol): 163 - 165°C. The R^ value is o.195 (on silica gel with chloroform/glacial acetic acid in a ratio of 19:1).
Analyse: C: beregnet: 25,51%, funnet: 25,53%. Analysis: C: calculated: 25.51%, found: 25.53%.
J: beregnet: 57,77%, funnet: 57,81%. J: calculated: 57.77%, found: 57.81%.
Eksempel 5 Example 5
2-(2,-/3"-(N-Metyl-acetylamino)-2l,,4",6,,-trijod-fenoksy_7-etoksy)-smørsyre. 2-(2,-/3"-(N-Methyl-acetylamino)-2l,,4",6,,-triiodo-phenoxy_7-ethoxy)-butyric acid.
5,5 g 2-/2'-(3"-acetylamino-2",4",6"-trijod-fenoksy)-etoksy_7-smørsyre oppløst i 8 ml 4N kaliumhydroksydoppløsning omsettes med 1,8 g metyljodid, oppløst i 1 ml aceton, ved 4 timers omrøring ved 4o°C. 5.5 g of 2-/2'-(3"-acetylamino-2",4",6"-triiodo-phenoxy)-ethoxy_7-butyric acid dissolved in 8 ml of 4N potassium hydroxide solution is reacted with 1.8 g of methyl iodide, dissolved in 1 ml of acetone, by stirring for 4 hours at 4o°C.
Isoleringen av det erholdte produkt skjer etter den i eksempel 1 beskrevne metode. The isolation of the product obtained takes place according to the method described in example 1.
Smeltepunkt (etter omkrystallisering fra en liten mengde etylacetat): Melting point (after recrystallization from a small amount of ethyl acetate):
118 - 12o°C. 118 - 12o°C.
Utbytte: 2,95 g (52,5% av det teoretiske). Yield: 2.95 g (52.5% of the theoretical).
Analyse: beregnet for C lo H lo J o N0C o Analysis: calculated for C lo H lo J o N0C o
Ekvivalentvekt: beregnet: 673,o3, funnet: 678. Equivalent weight: calculated: 673.o3, found: 678.
C: beregnet: 26,77%, funnet: 26,8o% C: calculated: 26.77%, found: 26.8o%
J: beregnet: 56,57%, funnet: 56,4o% J: calculated: 56.57%, found: 56.4o%
Rp-verdi: o,41 (på silikagel med kloroform/iseddik i forholdet 19:1). Oppløseligheter: Stoffet er uoppløselig i vann, men lett oppløselig i lavere alkoholer og i kloroform. Rp value: o.41 (on silica gel with chloroform/glacial acetic acid in a ratio of 19:1). Solubilities: The substance is insoluble in water, but easily soluble in lower alcohols and in chloroform.
Natrium- og N-metylglukaminsalt:»Jloo g/loo ml vandig oppløsning ved 2o°C. Sodium and N-methylglucamine salt: »Jloo g/loo ml aqueous solution at 2o°C.
Eksempel 6 Example 6
2-(2,-/3"-(N-Etyl-acetylamino)-2",4,',6,,-trijod-fenoksy_7-etoksy)-valeriBn8yre,. 2-(2,-/3"-(N-Ethyl-acetylamino)-2",4,',6,,-triiodo-phenoxy_7-ethoxy)-valeric acid.
Til 6,65 g 2-/2,-(3"-acetylamino-2",4<n>,6,,-trijod-fenoksy)-etoksy_7-valeriansyro (^o,ol mol), oppløst d lo ml vandig 4N kaliumhydroksydoppløsning (o,o4o mol), settes 2,35 g etyljodid, oppløst i 1,5 ml aceton. Det omrøres i 4 timer ved 4o°C. To 6.65 g of 2-[2,-(3"-acetylamino-2",4<n>,6,,-triiodo-phenoxy)-ethoxy_7-valeric acid (^0.ol mol), dissolved in d lo ml of aq. 4N potassium hydroxide solution (0.040 mol), add 2.35 g of ethyl iodide, dissolved in 1.5 ml of acetone. It is stirred for 4 hours at 4o°C.
Isoleringen av det ved nitrogenatomet etylerte produkt skjer etter den i de foregående eksempler beskrevne metode. The isolation of the product ethylated at the nitrogen atom takes place according to the method described in the preceding examples.
Det fåes 5,15 g amorft 2-(2'-/3MN-etyl-acetylamino)-2",4",6"-trijodfenoksy_7-etoksy)-valeriansyre. Utbyttet svarer til 74% av det teoretiske. 5.15 g of amorphous 2-(2'-/3MN-ethyl-acetylamino)-2",4",6"-triiodophenoxy_7-ethoxy)-valeric acid are obtained. The yield corresponds to 74% of the theoretical.
Analyse: beregnet for C._H„.J.NO,-Analysis: calculated for C._H„.J.NO,-
±1 i-i- å b ±1 i-i- to b
Ekvivalentvekt: beregnet: 7ol,12, funnet: 715 Equivalent weight: calculated: 7ol.12, found: 715
Oppløseligheter: Stoffet er uoppløselig i vann, men lett oppløselig i metanol. Solubilities: The substance is insoluble in water, but easily soluble in methanol.
Den som utgangsstoff anvendte 2-/2'-(3"-acetylamino-2",4",6"-trijod-fenoksy)-etoksy_/-valeriansyre fremstilles på følgende måte: The 2-[2'-(3"-acetylamino-2",4",6"-triiodo-phenoxy)-ethoxy_/-valeric acid used as starting material is prepared in the following way:
a) 2-(2'-kloretoksy)-valeriansyre-etylester. a) 2-(2'-chloroethoxy)-valeric acid ethyl ester.
27,5 g 2-(2'-kloretoksy)-valeronitril, oppløst i 4o ml etanol, behandles i 2 timer 27.5 g of 2-(2'-chloroethoxy)-valeronitrile, dissolved in 40 ml of ethanol, treated for 2 hours
under isavkjøling med hydrogenkloridgass, hvoretter den resulterende reaksjons-blanding får stå natten over og kokes deretter i 4 timer under tilbakeløpskjøling, hvorved det dannede iminoeter-hydroklorid med formelen under ice-cooling with hydrogen chloride gas, after which the resulting reaction mixture is allowed to stand overnight and then boiled for 4 hours under reflux, whereby the formed iminoether hydrochloride of the formula
Cl-CH2-CH2-0-CH-(C3H7)-C(OC2H5) <=> NH.HC1 Cl-CH2-CH2-0-CH-(C3H7)-C(OC2H5) <=> NH.HC1
utskilles. Reaksjonsblandingen røres ut i isvann, hvorved det dannes 2-(2<*->klor-etoksy )-valeriansyre-etylester, som ekstraheres med etyleter og destilleres etter avdampning av eteren. Kokepunktet er 119 - 124°C/12 mm Hg, utbytte 11,2 g (31,6% av det teoretiske). secreted. The reaction mixture is stirred into ice water, whereby 2-(2<*->chloro-ethoxy)-valeric acid ethyl ester is formed, which is extracted with ethyl ether and distilled after evaporation of the ether. The boiling point is 119 - 124°C/12 mm Hg, yield 11.2 g (31.6% of the theoretical).
2-(2'-kloretoksy)-valeriansyre-etylester kan også fremstilles ved omsetning 2-(2'-chloroethoxy)-valeric acid ethyl ester can also be prepared by reaction
av 2-klor-valeriansyre-etylester med etylenoksyd i henhold til D. Klamann et al, Liebigs Ann. Chem. 71o, 59 - 7o (1967) b) 2-/2,-(3"-Acetylamino-2",4",6"-trijod-fenoksy)-etoksy_7-valeriansyre-etylester. Denne forbindelse fremstilles av 19 g 3-acetylamino-2,4,6-trijod-fenol ved 4o timers kokning med 8,3 g 2-(2<*->kloretoksy)-valeriansyre-etylester i nærvær av o,o4 mol natriumetylat i ca. 3o ml etanol. Produktet isoleres etter avdampning av oppløsningsmidlet ved vasking med en liten mengde etyleter, opptagelse av det faste produkt i etylacetat, ekstraksjon med vann og natriumkarbonatoppløsning og avdampning av etylacetatet. Etter omkrystallisering av etanol er smeltepunktet llo - 111°C. Rp-verdi: o,61 (silikagel med kloroform/iseddik i forholdet 19:1). c) 2-/2'-(3"-Acetylamino-2",4",6"-trijod-fenoksy)-etoksy_7- valeriansyre. Denne forbindelse fåes ved forsåpning av den under b) fremstilte etylester (1,8 g) of 2-chloro-valeric acid ethyl ester with ethylene oxide according to D. Klamann et al, Liebigs Ann. Chem. 71o, 59 - 7o (1967) b) 2-(2,-(3"-Acetylamino-2",4",6"-triiodophenoxy)-ethoxy_7-valeric acid ethyl ester. This compound is prepared from 19 g of 3-acetylamino-2,4,6-triiodo-phenol by boiling for 40 hours with 8.3 g of 2-(2<*->chloroethoxy)-valeric acid ethyl ester in the presence of o.o4 mol of sodium ethylate for about. 3o ml of ethanol. The product is isolated after evaporation of the solvent by washing with a small amount of ethyl ether, absorption of the solid product in ethyl acetate, extraction with water and sodium carbonate solution and evaporation of the ethyl acetate. After recrystallization from ethanol, the melting point is llo - 111°C. Rp value: o.61 (silica gel with chloroform/glacial acetic acid in a ratio of 19:1). c) 2-[2'-(3"-Acetylamino-2",4",6"-triiodo-phenoxy)-ethoxy-7-valeric acid. This compound is obtained by saponification of the ethyl ester produced under b) (1.8 g)
med 3,5 ml IN hydroksydoppløsning i lo ml metanol og 3o ml vann ved 1 times kokning, avdampning av metanolen, ekstraksjon av den vandige oppløsning med etyleter og surgjøring av den vandige fase med saltsyre. Etter omkrystallisering av 5o%'s etanol er smeltepunktet 151°C. Rp-verdi: o,31 (på silikagel med kloroform/iseddik i forholdet 19:1). with 3.5 ml IN hydroxide solution in 10 ml methanol and 30 ml water by boiling for 1 hour, evaporation of the methanol, extraction of the aqueous solution with ethyl ether and acidification of the aqueous phase with hydrochloric acid. After recrystallization from 50% ethanol, the melting point is 151°C. Rp value: o.31 (on silica gel with chloroform/glacial acetic acid in a ratio of 19:1).
Eksempel ^ Example ^
2-(2,-/3*,-(N-Metyl-acetylamino)-2",4",6"-trijod-fenoksy_7-etoksy)-valeriansyre. 2-(2,-/3*,-(N-Methyl-acetylamino)-2",4",6"-triiodo-phenoxy_7-ethoxy)-valeric acid.
Til 6,65 g 2-/2'-(3"-acetylamino-2",4",6,,-trijod-fenoksy)-etoksy_7-valeriansyre ('Jo,ol mol) i lo ml 4N kaliumhydroksydoppløsning settes en oppløsning av 2,15 g metyljodid i 1,5 ml aceton, og reaksjonsblandingen omrøres i 3 - 4 timer ved 4o°C. Isoleringen av dette ved nitrogenatomet metylerte produkt foretas etter den i de ovenstående eksempler beskrevne metode. To 6.65 g of 2-/2'-(3"-acetylamino-2",4",6,,-triiodo-phenoxy)-ethoxy_7-valeric acid (10.00 mol) in 10 ml of 4N potassium hydroxide solution is added a solution of 2.15 g of methyl iodide in 1.5 ml of acetone, and the reaction mixture is stirred for 3 - 4 hours at 4o° C. The isolation of this product methylated at the nitrogen atom is carried out according to the method described in the above examples.
Det fåes 3,1 g amorft produkt med smeltepunkt^loo°C. 3.1 g of amorphous product with a melting point of 100°C is obtained.
Analyse: beregnet for C^gH^JgNOg Analysis: calculated for C^gH^JgNOg
Ekvivalentvekt: beregnet: 687,o9, funnet: 692 Equivalent weight: calculated: 687.o9, found: 692
C: beregnet: 27,97%, funnet: 28,25% C: calculated: 27.97%, found: 28.25%
J: beregnet: 55,42", funnet: 55,18% J: calculated: 55.42", found: 55.18%
Oppløseligheter: Stoffet er uoppløselig i vann, men lett oppløselig i lavere Solubilities: The substance is insoluble in water, but easily soluble in lower
alkoholer. alcohols.
Eksempel 8 Example 8
2-(2l-/3"-(N-Metyl-acetylamino)-2",4",6"-trijod-fenoksy_7-etoksy)-fenyleddiksyre. 2-(2l-/3"-(N-Methyl-acetylamino)-2",4",6"-triiodo-phenoxy_7-ethoxy)-phenylacetic acid.
3,5 g 2-/2f<->(3"-acetylamino-2",4",6"-trijod-fenoksy)-etoksy_7-fenyleddiksyre (o,oo5 mol) oppløses i 6 ml vann, som inneholder o,o2 mol kaliumhydroksyd, og til oppløsningen settes ved 2o°C under omrøring dråpevis en oppløsning av 1,1 g (o,o75 mol) metyljodid i o,5 ml aceton. Det omrøres i ytterligere 3-4 timer ved 4o°C, hvoretter reaksjonsoppløsningen fortynnes med 5o ml vann, og nøytrale stoffer fjernes ved ekstraksjon med etyleter. 3.5 g of 2-/2f<->(3"-acetylamino-2",4",6"-triiodo-phenoxy)-ethoxy_7-phenylacetic acid (0.oo5 mol) is dissolved in 6 ml of water, which contains o, o2 mol of potassium hydroxide, and a solution of 1.1 g (0.075 mol) methyl iodide in o.5 ml of acetone is added dropwise to the solution at 2o°C with stirring. It is stirred for a further 3-4 hours at 4o°C, after which the reaction solution is diluted with 5o ml of water, and neutral substances are removed by extraction with ethyl ether.
Den vandige fase befries for oppløst eter ved evakuering og surgjøres deretter med saltsyre. The aqueous phase is freed from dissolved ether by evacuation and then acidified with hydrochloric acid.
Den erholdte 2-(2'-/3"-(N-metyl-acetylamino)-2",4",6"-trijod-fenoksy_7-etoksy)-fenyleddiksyre (3,5 g) smelter ved loo - lo3°C. Produktet er amorft. The obtained 2-(2'-/3"-(N-methyl-acetylamino)-2",4",6"-triiodo-phenoxy_7-ethoxy)-phenylacetic acid (3.5 g) melts at 10-103°C . The product is amorphous.
Analyse: beregnet for C.QH.oJ„N0cAnalysis: calculated for C.QH.oJ„N0c
Ekvivalentvekt: beregnet: 721,08, funnet 728,5. Equivalent weight: calculated: 721.08, found 728.5.
Tynnskiktskromatogram: Medium: Silikagel "GF 254" Thin layer chromatogram: Medium: Silica gel "GF 254"
Utviklingsmiddel: Kloroform/iseddik i forholdet 19:1 Developer: Chloroform/glacial vinegar in a ratio of 19:1
Rp-verdi: o,61 Rp value: o.61
Oppløseligheter: Stoffet er uoppløselig i vann, men lett oppløselig i lavere alkoholer. Solubilities: The substance is insoluble in water, but easily soluble in lower alcohols.
Den som utgangsstoff anvendte 2-/2'-(3"-acetylamino-2",4",6"-trijodfenoksy)-etoksy_7-fenyleddiksyre fremstilles på følgende måte: The 2-[2'-(3"-acetylamino-2",4",6"-triiodophenoxy)-ethoxy_7-phenylacetic acid used as starting material is prepared in the following way:
a) »-(2-kloretoksy)-benzylklorid. a) »-(2-chloroethoxy)-benzyl chloride.
Til 49,2 g benzaldehyd-bis-(2-kloretyl)-acetal L Arbuzova et al, Chem. Abstracts To 49.2 g of benzaldehyde-bis-(2-chloroethyl)-acetal L Arbuzova et al, Chem. Abstracts
55, 19318 dc (1961), kokepunkt 16o - 162°C/2mm Hg7 i 39 ml acetylklorid settes o,5 ml tionylklorid. I 3o sekunder ledes hydrogenkloridgass til reaksjons-oppløsningen, hvoretter det oppvarmes under omrøring i 1 time ved 55 - 6o°C. Deretter får reaksjonsblandingen stå natten over, hvoretter den underkastes 55, 19318 dc (1961), boiling point 16o - 162°C/2mm Hg7 in 39 ml of acetyl chloride add o.5 ml of thionyl chloride. For 3o seconds, hydrogen chloride gas is introduced into the reaction solution, after which it is heated with stirring for 1 hour at 55 - 6o°C. The reaction mixture is then allowed to stand overnight, after which it is subjected to
fraksjonert destillasjon. Det erholdte a-(2-kloretoksy)-benzylklorid koker ved 128 - 13o°C/2 mm Hg. Utbyttet er 37 g (9o% av det teoretiske). fractional distillation. The resulting α-(2-chloroethoxy)-benzyl chloride boils at 128-130°C/2 mm Hg. The yield is 37 g (9o% of the theoretical).
b) ai-(2-kloretoksy)-benzyl-cyanid. b) α-(2-chloroethoxy)-benzyl cyanide.
Denne forbindelse fremstilles ved 3 timers oppvarming under omrøring av 17 g This compound is prepared by heating for 3 hours while stirring 17 g
^-(2-kloretoksy)-benzylklorid med 9 g kobber (I)-cyanid i 15 ml toluen ved 12o - 15o°C. Kokepunktet er 145 - 147°C/ 2 mm Hg, utbyttet er 11,5 g (7o% av det teoretiske). ^-(2-chloroethoxy)-benzyl chloride with 9 g of copper (I) cyanide in 15 ml of toluene at 12o - 15o°C. The boiling point is 145 - 147°C/ 2 mm Hg, the yield is 11.5 g (7o% of the theoretical).
c) 2-(2'-kloretoksy)-fenyleddiksyre-etylester. c) 2-(2'-chloroethoxy)-phenylacetic acid ethyl ester.
Denne forbindelse fremstilles av 9,8 g av det under b) erholdte nitril ved oppløsning This compound is prepared from 9.8 g of the nitrile obtained under b) by dissolution
av nitrilet i 15 ml etanol, tilføring av hydrogenkloridgass ved 15 - 2o°C, 4 timers kokning under tilbakeløpskjøling og forsåpning av det på denne måte erholdte iminoeter-hydroklorid med isvann. Kokepunktet er 155 - 157°C/2 mm Hg, utbyttet er lo g (84% av det teoretiske). of the nitrile in 15 ml of ethanol, addition of hydrogen chloride gas at 15 - 2o°C, boiling for 4 hours under reflux and saponification of the imino ether hydrochloride thus obtained with ice water. The boiling point is 155 - 157°C/2 mm Hg, the yield is log (84% of the theoretical).
2-(2'-kloretoksy)-fenyleddiksyre-etylester kan også fremstilles ved omsetning av 2-klor-fenyleddiksyre-etylester med etylenoksyd i nærvær av tetraetyl-ammoniumbromid i henhold til Klamann, Liebigs Annalen der Chemie 71o, 59 - 7o (1967). d) 2-/2t<3"-Acetylamino-2",4",6"-trijod-fenoksy)-etoksy_7-fenyleddiksyre-ety lester. 2-(2'-chloroethoxy)-phenylacetic acid ethyl ester can also be prepared by reacting 2-chloro-phenylacetic acid ethyl ester with ethylene oxide in the presence of tetraethylammonium bromide according to Klamann, Liebigs Annalen der Chemie 71o, 59 - 7o (1967) . d) 2-[2t<3"-Acetylamino-2",4",6"-triiodo-phenoxy)-ethoxy_7-phenylacetic acid ethyl ester.
Denne forbindelse fremstilles av 15,8 g 3-acetylamino-2,4,6-trijod-fenol ved 4o timers kokning med 8 g 2-(2'-kloretoksy)-fenyleddiksyre-etylester i nærvær av o,o3 mol natriumetylat i ca. 2o ml etanol. Etter avdestillering av oppløsningsmidlet isoleres produktet ved opptagelse i 2oo ml etylacetat, vasking med vann og natrium-karbonatoppløsning og avdestillering av etylacetatet. Smeltepunkt ( etter omkrystallisering fra 95%'s etanol): 136 - 137°C. Rp-verdi: o,64 (på silikagel med benzen/kloroform/iseddik i forholdet 7:3:2). This compound is prepared from 15.8 g of 3-acetylamino-2,4,6-triiodo-phenol by boiling for 40 hours with 8 g of 2-(2'-chloroethoxy)-phenylacetic acid ethyl ester in the presence of o.o3 mol of sodium ethylate for approx. . 2o ml of ethanol. After distilling off the solvent, the product is isolated by taking up in 2oo ml of ethyl acetate, washing with water and sodium carbonate solution and distilling off the ethyl acetate. Melting point (after recrystallization from 95% ethanol): 136 - 137°C. Rp value: o.64 (on silica gel with benzene/chloroform/glacial acetic acid in the ratio 7:3:2).
e) 2-/2'-(3"-Acetylamino-2",4",6"-trijod-fenoksy)-etoksy_7-fenyl-eddiksyre. Denne forbindelse fåes ved forsåpning av den under d) erholdte etylester (3,65 g) e) 2-(2'-(3"-Acetylamino-2",4",6"-triiodo-phenoxy)-ethoxy_7-phenyl-acetic acid. This compound is obtained by saponification of the ethyl ester obtained under d) (3.65 g)
i 3o ml 5o%'s etanol med 6 ml IN natriumhydroksydoppløsning ved kokning i lj time, avdampning av etanolen og surgjøring av den vandige fase med saltsyre. in 30 ml of 50% ethanol with 6 ml of 1N sodium hydroxide solution by boiling for 1 hour, evaporating the ethanol and acidifying the aqueous phase with hydrochloric acid.
Det rå produkt opptas i 15 ml kokende etylacetat, hvorved det først inntrer oppløsning og kort tid deretter krystallisasjon. Utbyttet er 2,4 g (68% av det teoretiske), smeltepunkt: 181-182°C, Rp-verdi: o,41 (på silikagel med benzen/ kloroform/iseddik i forholdet 7:3:2). The crude product is taken up in 15 ml of boiling ethyl acetate, whereby dissolution first occurs and crystallization shortly thereafter. The yield is 2.4 g (68% of the theoretical), melting point: 181-182°C, Rp value: o.41 (on silica gel with benzene/chloroform/glacial acetic acid in the ratio 7:3:2).
Eksempel 9 Example 9
2-(2'-/3i^(N-Etyl-acetylamino)-2",4",6"-trijod-fenoksy_7-etoksy)-fenyleddiksyre. 2-(2'-[3i^(N-Ethyl-acetylamino)-2",4",6"-triiodo-phenoxy-7-ethoxy)-phenylacetic acid.
Til 3,5 g 2-/2'-(3"-acetylamino-2",4",6"-trijod-fenoksy)-etoksy_7-feny1-eddiksyre 0v>o,oo5 mol) i 7 ml 2,85N kaliumhydroksydoppløsning (o,o2 mol) settes en oppløsning av 1,72 g etyljodid i 1 ml aceton, og reaksjonsblandingen omrøres i To 3.5 g of 2-[2'-(3"-acetylamino-2",4",6"-triiodo-phenoxy)-ethoxy_7-phenyl-acetic acid 0v>0.oo5 mol) in 7 ml of 2.85N potassium hydroxide solution (o.o2 mol) a solution of 1.72 g of ethyl iodide in 1 ml of acetone is added, and the reaction mixture is stirred in
3-4 timer ved 4o°C. 3-4 hours at 4o°C.
Det ved nitrogenatomet etylerte produkt isoleres etter den i eksempel 8 beskrevne metode. The product ethylated at the nitrogen atom is isolated according to the method described in example 8.
Smeltepunkt 85 - 9o°C (stoffet er amorft), utbytte 3,25 g (89,5% av det teoretiske). Melting point 85 - 9o°C (the substance is amorphous), yield 3.25 g (89.5% of the theoretical).
Analyse: beregnet for ^20^20^3N<^5Analysis: calculated for ^20^20^3N<^5
Ekvivalentvekt: beregnet: 735,13, funnet 745. Equivalent weight: calculated: 735.13, found 745.
Tynnskiktskromatogram: Medium: Silikagel "GF 254" Thin layer chromatogram: Medium: Silica gel "GF 254"
Utviklingsmiddel: Kloroform/benzen/iseddik i forholdet 3:7:2. Developer: Chloroform/benzene/glacial vinegar in the ratio 3:7:2.
Rp-verdi: o,63. Rp value: o.63.
Oppløseligheter: Stoffet er uoppløselig i vann, men lett oppløselig i lavere alkoholer. Solubilities: The substance is insoluble in water, but easily soluble in lower alcohols.
De ovenfor beskrevne, hittil ukjente forbindelser kan for administrasjons-formål anvendes sammen med en hvilken som helst egnet bærer, særlig i form av The above-described, hitherto unknown compounds can be used for administration purposes together with any suitable carrier, particularly in the form of
tabletter, granulater, kapsler, dragéer, globuler, clysma, suspensjoner eller oppløsninger. Det foretrekkes vanligvis orale preparater. tablets, granules, capsules, dragées, globules, enemas, suspensions or solutions. Oral preparations are usually preferred.
Såvel de frie syrer som deres metall- og aminsalter eller deres estere kan anvendes. Both the free acids and their metal and amine salts or their esters can be used.
Eksempel 10 Example 10
2-(2,-/3"-(N-etyl-acetylamino)-2,<l>,4",6"-trijod-fenoksY7-etoksy)-propionsyre 2-(2,-/3"-(N-ethyl-acetylamino)-2,<1>,4",6"-triiodo-phenoxy-7-ethoxy)-propionic acid
Fremstilling ifølge fremgangsmåte b: Production according to method b:
Etylester: Ethyl Ester:
Denne fåes fra 16,7 g 3-(N-etyl-acetylamino)-2,4,6-trijod-fenol (o,o3 mol) This is obtained from 16.7 g of 3-(N-ethyl-acetylamino)-2,4,6-triiodo-phenol (o.o3 mol)
ved omsetning med 5,94 g 2-(2'-kloretoksy)-propionsyre-etylester i nærvær av o,o33 mol natriumetylat i 2o ml etanol ved 4o timers kokning vinder tilbake-løpskjøling ved en badtemperatur på 95-loo°C. Oppløsningsmiddelet avdampes, og residuet opptas i 18o ml kloroform og loo ml vann. Den organiske fase skilles fra, vaskes med vann, tørres og inndampes. Residuet (16,4 g, by reaction with 5.94 g of 2-(2'-chloroethoxy)-propionic acid ethyl ester in the presence of o.o33 mol of sodium ethylate in 2o ml of ethanol at 4o hours of boiling, reflux cooling takes place at a bath temperature of 95-loo°C. The solvent is evaporated, and the residue is taken up in 180 ml of chloroform and 100 ml of water. The organic phase is separated, washed with water, dried and evaporated. The residue (16.4 g,
hvilket svarer til 77% av det teoretiske) består av harpiksaktig, krystallinsk 2-(2'-/3"-(N-etyl-acetylamino)-2",4",6"-trij od-fenoksy7-etoksy)-propionsyre-etylester. which corresponds to 77% of the theoretical) consists of resinous, crystalline 2-(2'-/3"-(N-ethyl-acetylamino)-2",4",6"-triiod-phenoxy7-ethoxy)-propionic acid -ethyl ester.
Tynnsjiktskromatogram på silikagel: R^-verdi = o,78 (benzen/metanol/ iseddik i forholdet 3o:16:8). Thin-layer chromatogram on silica gel: R^-value = o.78 (benzene/methanol/glacial acetic acid in the ratio 3o:16:8).
Analyse: beregnet for C^H^JgNO,., molvekt: 7ol,o9. Analysis: calculated for C^H^JgNO,., molecular weight: 7ol,o9.
C: beregnet: 29,12%, funnet: 29,42%. C: calculated: 29.12%, found: 29.42%.
J: beregnet: 54,31%, funnet: 52,9o%. J: calculated: 54.31%, found: 52.9o%.
Fri syre: Free acid:
15,2 g av ovennevnte etylester (o,o21 mol) forsåpes ved 1 times kokning med 1,6 g natriumhydroksyd i 3o ml metanol og 9o ml vann. Metanolen avdestilleres, det vandige residuum ekstraheres med dietyleter og surgjøres. Det herved utfelte produkt ekstraheres med etylacetat. Ekstrakten inndampes. Residuet krystalliseres og kan nu omkrystalliseres fra litt etylacetat eller 5o%ig vandig etanol. 15.2 g of the above-mentioned ethyl ester (0.021 mol) is saponified by boiling for 1 hour with 1.6 g of sodium hydroxide in 30 ml of methanol and 90 ml of water. The methanol is distilled off, the aqueous residue is extracted with diethyl ether and acidified. The thus precipitated product is extracted with ethyl acetate. The extract is evaporated. The residue is crystallized and can now be recrystallized from a little ethyl acetate or 50% aqueous ethanol.
Utbytte: 8,5 g (6o% av det teoretiske). Yield: 8.5 g (6o% of the theoretical).
Smeltepunkt: 15o - 151°C. Melting point: 15o - 151°C.
Det som utgangsmateriale anvendte 3-(N-etyl-acetylamino)-2,4,6-trijod-fenol fremstilles som følger: Til en oppløsning av lo5,6 g (o,2 mol) 3-acetylamino-2,4,6-trijod-fenol i loo ml (o,8 mol) 4N kaliumhydroksydoppløsning dryppes ved rom-temperatur under omrøring 31 g (o,2 mol) etyljodid, oppløst i 16 ml aceton. Reaksjonsoppløsningen omrøres i 3 timer ved 4o - 45°C. Den vandige fase befries for oppløst' eter ved evakuering og helles deretter ut i 6oo ml 4% ig saltsyre. The 3-(N-ethyl-acetylamino)-2,4,6-triiodo-phenol used as starting material is prepared as follows: To a solution of 105.6 g (0.2 mol) 3-acetylamino-2,4,6 -triiodo-phenol in 10 ml (0.8 mol) of 4N potassium hydroxide solution is added dropwise at room temperature with stirring 31 g (0.2 mol) of ethyl iodide, dissolved in 16 ml of acetone. The reaction solution is stirred for 3 hours at 4o - 45°C. The aqueous phase is freed from dissolved ether by evacuation and is then poured into 600 ml of 4% hydrochloric acid.
Bunnfallet omfelles med saltsyre fra fortynnet natriumhydroksyd-oppløsning. The precipitate is reprecipitated with hydrochloric acid from dilute sodium hydroxide solution.
Til videre rensning av den således dannede 3-(N-etyl-acetylamino)-2,4,6-trijod-fenol isoleres dets forholdsvis lite oppløselige ammoniumsalt. For further purification of the thus formed 3-(N-ethyl-acetylamino)-2,4,6-triiodo-phenol, its relatively poorly soluble ammonium salt is isolated.
Etter frigjørelse av saltet fåes 78 g (7o% av det teoretiske) ren 3-(N-etyl-acetylamino)-2,4,6-trijod-fenol med smeltepunkt 147°C. After liberation of the salt, 78 g (70% of the theoretical) of pure 3-(N-ethyl-acetylamino)-2,4,6-triiodo-phenol with a melting point of 147°C are obtained.
Analyse: beregnet for C, H, J„NO„ Analysis: calculated for C, H, J„NO„
J ° lo lo 3 2 J ° lo lo 3 2
Ekvivalentvekt: beregnet: 556,91, funnet: 555 Equivalent weight: calculated: 556.91, found: 555
C: beregnet: 21,56%, funnet: 21,6o% C: calculated: 21.56%, found: 21.6o%
J: beregnet: 68,37%, funnet: 68,32%. Tynnsjiktskromatogram på silikagel: Rp = o,62 (etylacetat/isopropanol/ ammoniakk i forholdet 11:7:4). J: calculated: 68.37%, found: 68.32%. Thin-layer chromatogram on silica gel: Rp = o.62 (ethyl acetate/isopropanol/ammonia in the ratio 11:7:4).
Som biprodukt i den eteriske ekstrakt finnes etyleteren av 3-(N-etyl-acetylamino)-2,4,6-trij od-fenol. The ethyl ether of 3-(N-ethyl-acetylamino)-2,4,6-triiod-phenol is found as a by-product in the ethereal extract.
Eksempel 11, Example 11,
2-( 2'-/ 3"-( N- metyl- acetylamino)~ 2 "} 4", 6"- trijod- fenoksy7- etoksy)- propionsyre 2-( 2'-/ 3"-( N- methyl- acetylamino)~ 2 "} 4", 6"- triiodo-phenoxy7- ethoxy)- propionic acid
På analog måte som beskrevet detaljert i eksempel 1 omsettes 13 g 2-/2'-(3"-acetylamino-2",4",6"-trijod-fenoksy)-etoksv7-propionsyre (o,o2 mol), oppløst i 2o ml 4N kaliumhydroksydoppløsning, med 4,15 g metyljodid (o,o3 mol). Utbyttet er 8,o5 g (61,5% av det teoretiske). In an analogous manner as described in detail in example 1, 13 g of 2-[2'-(3"-acetylamino-2",4",6"-triiodo-phenoxy)-ethoxysv7-propionic acid (0.02 mol), dissolved in 2o ml of 4N potassium hydroxide solution, with 4.15 g of methyl iodide (o.o3 mol). The yield is 8.05 g (61.5% of the theoretical).
Smeltepunkt: 135°C Melting point: 135°C
Analyse: beregnet for C^H^JgNOg Analysis: calculated for C^H^JgNOg
Ekvivalentvekt: beregnet: 659,ol, funnet: 662 Equivalent weight: calculated: 659,ol, found: 662
C: beregnet: 25,51%, funnet: 25,58% C: calculated: 25.51%, found: 25.58%
J: beregnet: 57,77%, funnet: 57,9o% Tynnsjiktskromatogram på silikagel: Rp = o,38 (Utviklingsmiddel: kloroform/ iseddik i forholdet 19:1). J: calculated: 57.77%, found: 57.9o% Thin-layer chromatogram on silica gel: Rp = o.38 (Developing agent: chloroform/glacial acetic acid in the ratio 19:1).
Oppløseligheter: i g/loo ml oppløsningsmiddel ved Solubilities: in g/loo ml solvent at
Eksempel 12 Example 12
2-(2'-/3"-(N-metyl-acetylamino)-2",4",6"-trijod-fenoksv7-etoksy)-f enyleddiksyre 2-(2'-/3"-(N-methyl-acetylamino)-2",4",6"-triiodo-phenoxy-7-ethoxy)-phenylacetic acid
Fremstilling ifølge fremgangsmåte b: Production according to method b:
Til 67 g natrium-3-(N-metyl-acetylamino)-2,4,6-trijod-fenolat To 67 g of sodium 3-(N-methyl-acetylamino)-2,4,6-triiodo-phenolate
(o,118 mol), oppløst i 6o ml varmt dimetylacetamid, settes dråpevis under om- (o.118 mol), dissolved in 6o ml of warm dimethylacetamide, is added dropwise under
raring 3o g 2-(2'-kloretoksy)-fenyleddiksyre-etylester. Reaksjonsblandingen omrøres ved llo°C i 4o timer. raring 3o g 2-(2'-chloroethoxy)-phenylacetic acid ethyl ester. The reaction mixture is stirred at llo°C for 40 hours.
Det dannede produkt forsåpes i vandig metanol med natriumhydroksyd-oppløsning. The product formed is saponified in aqueous methanol with sodium hydroxide solution.
Den rå 2- (21 -/3 "- (N-mety1-acetylamino)-2",4",6"-trij od-fenoksy/- etoksy)-fenyleddiksyre oppløses i litt varm etanol, og ved tilsetning av cykloheksylamin omdannes denne til cykloheksylaminsaltet, som utkrystalliserer av sin alkoholiske oppløsning. Saltet skilles fra, oppløses i en stor mengde vann og spaltes ved tilsetning av fortynnet saltsyre. The crude 2-(21 -/3 "-(N-methyl-acetylamino)-2,4,6"-triiod-phenoxy/- ethoxy)-phenylacetic acid is dissolved in slightly warm ethanol, and on addition of cyclohexylamine is converted this to the cyclohexylamine salt, which crystallizes out of its alcoholic solution. The salt is separated, dissolved in a large amount of water and decomposed by the addition of dilute hydrochloric acid.
På denne måte fåes 5o,2 g produkt med smeltepunkt 83-84°C. Utbyttet er 54% av det teoretiske. In this way, 50.2 g of product with a melting point of 83-84°C is obtained. The yield is 54% of the theoretical.
Analyse: beregnet for CloH1oJoN0 Analysis: calculated for CloH1oJoN0
ly lo 0 3 ly lo 0 3
Ekvivalentvekt: beregnet: 721,08, funnet: 723. Equivalent weight: calculated: 721.08, found: 723.
C: beregnet: 31,64%, funnet: 31,63%. C: calculated: 31.64%, found: 31.63%.
J: beregnet: 52,8o%, funnet: 52,82% Tynnsjiktskromatogram på silikagel: Rp = o,46 (utviklingsmiddel: etylacetat/isopropanol/ammoniak i forholdet 11:7:4). J: calculated: 52.8o%, found: 52.82% Thin layer chromatogram on silica gel: Rp = o.46 (developing agent: ethyl acetate/isopropanol/ammonia in the ratio 11:7:4).
Eksempel 13 Example 13
2- (3' -/3"- (N-metyl-acetylamino )-2", 4", 6 "-tri j od-f enoksy7-propoksy )-f enyl-eddiksyre. 9 g 2-/3'-(3"-acetylamino-2",4",6"-trijod-fenoksy)-propoksy7-fenyleddiksyre oppløses i 17 ml vann, som inneholder o,o52 mol kaliumhydroksyd, og det tilsettes 2,56 g metyljodid i 1,5 ml aceton. Det røres i 3 til 4 timer ved 4o°C. 2-(3'-[3"-(N-methyl-acetylamino)-2",4",6"-triiod-phenoxy7-propoxy)-phenylacetic acid. 9 g of 2-/3'-(3"-acetylamino-2",4",6"-triiodo-phenoxy)-propoxy7-phenylacetic acid are dissolved in 17 ml of water, which contains 0.052 mol of potassium hydroxide, and 2, 56 g of methyl iodide in 1.5 ml of acetone. It is stirred for 3 to 4 hours at 4o°C.
Opparbeidningen skjer på den i eksempel .8 anførte måte. Processing takes place in the manner stated in example .8.
Utbytte: 8,6 g (94% av det teoretiske). Yield: 8.6 g (94% of theoretical).
Smeltepunkt: 78°C (sintring ved 71°C) Melting point: 78°C (sintering at 71°C)
Analyse: beregnet for C^I^<Jg>NOj. Analysis: calculated for C^I^<Jg>NOj.
Ekvivalentvekt: beregnet: 735,13, funnet: 738 Equivalent weight: calculated: 735.13, found: 738
C: beregnet: 32,67%, funnet: 32,65% C: calculated: 32.67%, found: 32.65%
J: beregnet: 51,79%, funnet: 51,76%. J: calculated: 51.79%, found: 51.76%.
Tynnsjiktskromatogram på silikagel: Rp = o,57. (Utviklingsmiddel: kloroform/benzen/iseddik i forholdet 3:7:2). Thin layer chromatogram on silica gel: Rp = o.57. (Developing agent: chloroform/benzene/glacial vinegar in the ratio 3:7:2).
Oppløseligheter: i g/loo ml oppløsningsmiddel ved 2o°C Solubilities: in g/loo ml of solvent at 2o°C
Fri syre: Vann uoppløselig Free acid: Water insoluble
metanol loo methanol loo
etanol loo ethanol loo
kloroform loo chloroform loo
Natriumsalt: Vann 3o% Sodium salt: Water 3o%
N-metyl- N-methyl-
glukaminsalt: Vann 5o%. Glucamine salt: Water 5o%.
Den som utgangsmateriale anvendte 2-/3,-(3"-acetylamino-2",4",6"-trijod-fenoksy)-propoksy7-fenyleddiksyre fremstilles som følger: The 2-[3,-(3"-acetylamino-2",4,6"-triiodo-phenoxy)-propoxy7-phenylacetic acid used as starting material is prepared as follows:
a) Benzaldehyd-bis-(3-klorpropyl)-acetat: a) Benzaldehyde-bis-(3-chloropropyl)-acetate:
63 g benzaldehyd og 17o g 3-klorpropanol kokes under tilbakeløpskjøling 63 g of benzaldehyde and 170 g of 3-chloropropanol are boiled under reflux
i 4o timer i 15o ml toluen i nærvær av o,3 g p-toluensulfoklorid. Reaksjons-vannet fjernes ved azeotrop destillasjon. Produktet destilleres. for 40 hours in 150 ml of toluene in the presence of 0.3 g of p-toluene sulphochloride. The reaction water is removed by azeotropic distillation. The product is distilled.
Kokepunkt: 127 - 132°C/o,o5 mm Hg, n^0'5 C =1,512. Boiling point: 127 - 132°C/o.o5 mm Hg, n^0'5 C =1.512.
Utbytte: 14o,5 g (84,5% av det teoretiske). Yield: 14o.5 g (84.5% of the theoretical).
b) «- (3-klorpropoksy)-benzylklorid: b) "-(3-Chloropropoxy)-benzyl chloride:
En blanding av 132 g av acetat a) og loo g acetylklorid behandles i A mixture of 132 g of acetate a) and loo g of acetyl chloride is treated in
1 minutt med HCl-gass og oppvarmes i 2 timer til 7o°C. Reaksjonsproduktet destilleres fraksjonert. 1 minute with HCl gas and heated for 2 hours to 7o°C. The reaction product is fractionally distilled.
Kokepunkt: 128 - 131°C/2 mm Hg, nD<21> C = 1,526. Boiling point: 128 - 131°C/2 mm Hg, nD<21> C = 1.526.
Utbytte: 74 g. Yield: 74 g.
c) <*-(3-klorpropoksy)-benzylcyanid fåes fra 65,7 g <*-(3-klorpropoksy)-benzylklorid ved oppvarmning i 3 timer med 3o g kobber(I)cyanid i 5o ml toluen. c) <*-(3-chloropropoxy)-benzyl cyanide is obtained from 65.7 g of <*-(3-chloropropoxy)-benzyl chloride by heating for 3 hours with 30 g of copper (I) cyanide in 50 ml of toluene.
Kokepunkt: 148 - 151°C/2 mm Hg, n 21,3 ° =1,515. Boiling point: 148 - 151°C/2 mm Hg, n 21.3 ° =1.515.
Utbytte: 46,6 g (73,5% av det teoretiske). Yield: 46.6 g (73.5% of the theoretical).
d) 2-(3'-klorpropoksy)-fenyleddiksyre-etylester fåes ved behandling d) 2-(3'-chloropropoxy)-phenylacetic acid ethyl ester is obtained by treatment
av nitrilet c) (46,2 g) med etanol-HCl og forsåpning av det derved dannede of the nitrile c) (46.2 g) with ethanol-HCl and saponification of the thus formed
iminoeter-hydroklorid. iminoether hydrochloride.
Kokepunkt: 152 - 156°C/2 mm Hg, i^<20>'<5> = l,5o23. Boiling point: 152 - 156°C/2 mm Hg, i^<20>'<5> = 1.5o23.
Utbytte: 5o,35 g (89% av det teoretiske). Yield: 50.35 g (89% of the theoretical).
e) 2-/3'-(3"-acetylamino-2",4",6"-trijodfenoksy)-propoksy7-fenyleddiksyre-ety lester fåes ved oppvarmning i 48 timer til koketemperatur av e) 2-/3'-(3"-acetylamino-2",4",6"-triiodophenoxy)-propoxy7-phenylacetic acid ethyl ester is obtained by heating for 48 hours to the boiling temperature of
52,8 g (o,l mol) 3-acetylamino-2,4,6-trijod-fenol i nærvær av o,ll mol Na-O-CjH,. med 28,3 g (o,ll mol) 2-(3'-klor-propoksy)-fenyleddiksyre-etylester i 7o ml etanol. 52.8 g (0.1 mol) of 3-acetylamino-2,4,6-triiodophenol in the presence of 0.1 mol Na-O-CjH,. with 28.3 g (0.11 mol) 2-(3'-chloro-propoxy)-phenylacetic acid ethyl ester in 70 ml of ethanol.
Smeltepunkt: 65 - 67°C. Melting point: 65 - 67°C.
Utbytte: 72,2 * (96,5% av det teoretiske). Yield: 72.2 * (96.5% of the theoretical).
f) 2-/3'-(3"-acetylamino-2",4",6"-trijod-fenoksy)-propoks_7~fenyleddiksyre fåes ved forsåpning av etylesteren e) (5o g) med NaOH i etanol/ f) 2-/3'-(3"-acetylamino-2",4",6"-triiodo-phenoxy)-propoxy_7-phenylacetic acid is obtained by saponification of the ethyl ester e) (50 g) with NaOH in ethanol/
vann. water.
Smeltepunkt (etter behandling i kokende etylacetat) : 154 - 157°C. Melting point (after treatment in boiling ethyl acetate) : 154 - 157°C.
Utbytte: 36,5 ? (75% av det teoretiske). Yield: 36.5 ? (75% of the theoretical).
Eksempel I4 Example I4
2-(3,-/3"-(N-etyl-acetylamino)-2"'j<1>l",6"-trijod-fenoksy7-propoksy)-fenyleddiksyre 9 g 2-/3 •-( <3>"-acet<y>lamino-<2>" ,<4>" ,<6>"-trijod-fenoksy)-propoksy7-fenyleddiksyre omsettes i nærvær av o,o52 mol KOH med 2,8 g etyljodid. 2-(3,-/3"-(N-ethyl-acetylamino)-2"'j<1>1",6"-triiodo-phenoxy7-propoxy)-phenylacetic acid 9 g 2-/3 •-( <3 >"-acet<y>lamino-<2>" ,<4>" ,<6>"-triiodo-phenoxy)-propoxy7-phenylacetic acid is reacted in the presence of o.o52 mol of KOH with 2.8 g of ethyl iodide.
Utbytte: 9 g (96% av det teoretiske). Yield: 9 g (96% of the theoretical).
Smeltepunkt: 76°C (sintring ved 7o°C). Melting point: 76°C (sintering at 7o°C).
Analyse: beregnet for C2iH22<J>3N05Analysis: calculated for C2iH22<J>3N05
Ekvivalentvekt: beregnet: 749,16, funnet: 742 Equivalent weight: calculated: 749.16, found: 742
C: beregnet: 33,66%, funnet: 33,88% C: calculated: 33.66%, found: 33.88%
J: beregnet: 5o,82%, funnet: 5o,5o% Tynnsjiktskromatogram på silikagel: Rp = o,58. (Utviklingsmiddel: benzen/kloroform/iseddik i forholdet 7:3:2.) J: calculated: 5o.82%, found: 5o.5o% Thin layer chromatogram on silica gel: Rp = o.58. (Developing agent: benzene/chloroform/glacial vinegar in the ratio 7:3:2.)
Oppløseligheter: Denne hittil ukjente forbindelse er uoppløselig i vann, Solubilities: This hitherto unknown compound is insoluble in water,
derimot særdeles lettoppløselig i metanol, etanol og kloroform. on the other hand, extremely easily soluble in methanol, ethanol and chloroform.
Natrium- og N-metylglukaminsaltene er allerede ved rom-temperatur lettoppløselige i vann. The sodium and N-methylglucamine salts are already easily soluble in water at room temperature.
Natriumsalt: ca. 28 g/loo ml vann. N-metylglukaminsalt: ca. 5o g/loo ml vann. Sodium salt: approx. 28 g/loo ml of water. N-methylglucamine salt: approx. 5o g/loo ml of water.
Eksempel 15 Example 15
2-(4l-/3l,-(N-metyl-acetylamino)-2",4",6"-trijod-fenoksy7-butoksy)-fenyleddiksyre 37 g 2-/4•-(3"-acetylamino-2",4",6"-trijod-fenoksy)-butoksy7-:fenyleddiksyre (o,o5 mol) omsettes i nærvær av o,2 mol kaliumhydroksydoppløsning med 8,5 g metyljodid. 2-(4l-/3l,-(N-methyl-acetylamino)-2",4",6"-triiodo-phenoxy7-butoxy)-phenylacetic acid 37 g 2-/4•-(3"-acetylamino-2" ,4",6"-triiodo-phenoxy)-butoxy7-:phenylacetic acid (0.05 mol) is reacted in the presence of 0.2 mol of potassium hydroxide solution with 8.5 g of methyl iodide.
Utbytte: 33 g (88% av det teoretiske). Yield: 33 g (88% of the theoretical).
Smeltepunkt: 75°C (sintring ved 68°C). Melting point: 75°C (sintering at 68°C).
Denne til å begynne med fremkomne, lavtsmeltende, ustabile krystall-modifikasjon av produktet omdannes ved oppvarmning i 15o ml etylacetat til dets stabile modifikasjon som smelter ved 18o - 183 oC. This initially formed, low-melting, unstable crystal modification of the product is converted by heating in 15o ml of ethyl acetate into its stable modification which melts at 18o - 183 oC.
Analyse: beregnet for C..H-„J„NO,- Analysis: calculated for C..H-„J„NO,-
21 22. o o 21 22. o o
Ekvivalentvekt: beregnet: 749,16, funnet: 744 Equivalent weight: calculated: 749.16, found: 744
C: beregnet: 33,67%, funnet: 33,58% C: calculated: 33.67%, found: 33.58%
J: beregnet: 5o,82%, funnet: 5o,77%. J: calculated: 5o.82%, found: 5o.77%.
Tynnsjiktskromatogram på silikagel: Rp = o,57 (Utviklingsmiddel: etylacetat/isopropanol/ammoniakk i forholdet 11:7:4). Thin-layer chromatogram on silica gel: Rp = o.57 (Developing agent: ethyl acetate/isopropanol/ammonia in the ratio 11:7:4).
Oppløseligheter: Natriumsaltets oppløselighet er ca. 5o g/loo ml vann, og N-metylglukaminsaltets oppløselighet ca. loo g/loo ml vann. Solubility: The solubility of the sodium salt is approx. 5o g/loo ml of water, and the solubility of the N-methylglucamine salt approx. loo g/loo ml of water.
Den som utgangsmateriale anvendte 2-/4'-(3"-acetylamino-2",4",6"-f.rijod-fenoksy)-butoksy7-fenyleddiksyre fremstilles analogt med dens homologe forbindelse, som er beskrevet i eksempel 13 a), b), c), d), e) og f). The 2-[4'-(3"-acetylamino-2",4",6"-triiodo-phenoxy)-butoxy7-phenylacetic acid used as starting material is prepared analogously to its homologous compound, which is described in example 13 a) , b), c), d), e) and f).
a) Benzaldehyd-bis-(4-klorbutyl)-acetat: a) Benzaldehyde bis-(4-chlorobutyl) acetate:
Kokepunkt: 142 - 144°C/o,o7 mm Hg, i^<20»5> = 1,512 Boiling point: 142 - 144°C/o.o7 mm Hg, i^<20»5> = 1.512
b) *-(4-klorbutoksy)-benzylklorid: b) *-(4-chlorobutoxy)-benzyl chloride:
_ ^qO _ ^qO
Kokepunkt: 118 - 121 C/o,o5 mm Hg. nD = 1,521 Boiling point: 118 - 121 C/o.o5 mm Hg. nD = 1.521
c) (4-klorbutoksy)-benzyl-cyanid: c) (4-chlorobutoxy)-benzyl cyanide:
Kokepunkt: 16o - 164°C/2 mm Hg. Boiling point: 16o - 164°C/2 mm Hg.
d) 2-(4<*->klorbutoksy)-fenyleddiksyre-etylester: d) 2-(4<*->chlorobutoxy)-phenylacetic acid ethyl ester:
Kokepunkt: 149 - 154°C/2 mm Hg. n^0'5 = l,5o2 Boiling point: 149 - 154°C/2 mm Hg. n^0'5 = 1.5o2
e) 2-A•-(3"-acetylamino-2",4",6"-trijod-fenoksy)-butoksy?-fenyleddiksyre-ety lester: e) 2-A•-(3"-acetylamino-2",4",6"-triiodo-phenoxy)-butoxy?-phenylacetic acid ethyl ester:
Smeltepunkt: 124°C. Melting point: 124°C.
f) 2-/4'-(3"-acetylamino-2",4",6"-trijod-fenoksy)-butoksy7-fenyleddiksyre: f) 2-/4'-(3"-acetylamino-2",4",6"-triiodo-phenoxy)-butoxy7-phenylacetic acid:
Smeltepunkt: 124°C (sintring ved 118°C) Melting point: 124°C (sintering at 118°C)
Eksempel 16 Example 16
2-(4'-/3"-(N-etyl-acetylamino)-2",4",6"-trijod-fenoksy7-butoksy)-fenyleddiksyre 2-(4'-/3"-(N-ethyl-acetylamino)-2",4",6"-triiodo-phenoxy7-butoxy)-phenylacetic acid
Dette produkt fåes ved omsetning av forbindelsen fra eksempel 15 f) This product is obtained by reacting the compound from example 15 f)
(37 g) med 9,4 g etyljodid i o,2 mol vandig kaliumhydroksydoppløsning. Utbytte: 32 g (85% av det teoretiske). (37 g) with 9.4 g of ethyl iodide in 0.2 mol aqueous potassium hydroxide solution. Yield: 32 g (85% of the theoretical).
Smeltepunkt: a) etter utfelning: 74°C (sintring ved 66°C). Melting point: a) after precipitation: 74°C (sintering at 66°C).
b) etter oppvarmning i etylacetat: 175 - 177°C. b) after heating in ethyl acetate: 175 - 177°C.
Analyse: beregnet for C22H24J3N°5Analysis: calculated for C22H24J3N°5
Ekvivalentvekt: beregnet: 763,18, funnet: 77o Equivalent weight: calculated: 763.18, found: 77o
C: beregnet: 34,62%, funnet: 34,60% C: calculated: 34.62%, found: 34.60%
J: beregnet: 49,89%, funnet: 49,86% Tynnsjiktskromatogram på silikagel: Rp = o,58 (Utviklingsmiddel: etylacetat/isopropanol/ammoniakk i forholdet 11:7:4). J: calculated: 49.89%, found: 49.86% Thin layer chromatogram on silica gel: Rp = o.58 (Developing agent: ethyl acetate/isopropanol/ammonia in the ratio 11:7:4).
Oppløseligheter: natriumsalt: 44 g/loo ml vann H-metylglukaminsalt: ca. loo g/loo ml vann. Solubilities: sodium salt: 44 g/loo ml water H-methylglucamine salt: approx. loo g/loo ml of water.
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH748267A CH483262A (en) | 1967-05-29 | 1967-05-29 | New X-ray contrast media and processes for their production |
Publications (1)
Publication Number | Publication Date |
---|---|
NO121611B true NO121611B (en) | 1971-03-22 |
Family
ID=4325807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO1936/68A NO121611B (en) | 1967-05-29 | 1968-05-16 |
Country Status (12)
Country | Link |
---|---|
US (1) | US3553259A (en) |
AT (2) | AT284825B (en) |
BE (1) | BE715799A (en) |
CH (2) | CH483262A (en) |
DE (1) | DE1768553B1 (en) |
DK (1) | DK123762B (en) |
ES (1) | ES354410A1 (en) |
FR (2) | FR1596453A (en) |
GB (1) | GB1228851A (en) |
NL (1) | NL6807381A (en) |
NO (1) | NO121611B (en) |
SE (1) | SE352340B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4314055A (en) * | 1975-09-29 | 1982-02-02 | Mallinckrodt, Inc. | 3,5-Disubstituted-2,4,6-triiodoanilides of polyhydroxy-monobasic acids |
US5310538A (en) * | 1993-03-11 | 1994-05-10 | Sterling Winthrop Inc. | Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract |
US5348727A (en) * | 1993-03-11 | 1994-09-20 | Sterling Winthrop Inc. | Compositions of iodophenoxy alkylene ethers for visualization of the gastrointestinal tract |
-
1967
- 1967-05-29 CH CH748267A patent/CH483262A/en not_active IP Right Cessation
- 1967-05-29 CH CH1533669A patent/CH494576A/en unknown
-
1968
- 1968-05-02 SE SE05927/68A patent/SE352340B/xx unknown
- 1968-05-07 GB GB1228851D patent/GB1228851A/en not_active Expired
- 1968-05-14 US US728894A patent/US3553259A/en not_active Expired - Lifetime
- 1968-05-14 DK DK223568AA patent/DK123762B/en unknown
- 1968-05-16 NO NO1936/68A patent/NO121611B/no unknown
- 1968-05-24 NL NL6807381A patent/NL6807381A/xx unknown
- 1968-05-25 DE DE19681768553 patent/DE1768553B1/en not_active Withdrawn
- 1968-05-27 AT AT60669A patent/AT284825B/en not_active IP Right Cessation
- 1968-05-27 AT AT506668A patent/AT277452B/en not_active IP Right Cessation
- 1968-05-28 FR FR1596453D patent/FR1596453A/fr not_active Expired
- 1968-05-28 ES ES354410A patent/ES354410A1/en not_active Expired
- 1968-05-28 FR FR153106A patent/FR7769M/fr not_active Expired
- 1968-05-28 BE BE715799D patent/BE715799A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AT284825B (en) | 1970-09-25 |
CH494576A (en) | 1970-08-15 |
DE1768553B1 (en) | 1970-09-16 |
ES354410A1 (en) | 1969-11-01 |
BE715799A (en) | 1968-11-28 |
DK123762B (en) | 1972-07-31 |
NL6807381A (en) | 1968-12-02 |
FR1596453A (en) | 1970-06-22 |
AT277452B (en) | 1969-12-29 |
FR7769M (en) | 1970-03-23 |
US3553259A (en) | 1971-01-05 |
CH483262A (en) | 1969-12-31 |
SE352340B (en) | 1972-12-27 |
GB1228851A (en) | 1971-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4070539A (en) | [1-Oxo-2-halo(or hydrogen) indanyloxy]-alkanoic acid | |
US4190671A (en) | Chalcone derivatives | |
SU552032A3 (en) | The method of obtaining piperazine derivatives pyriazopyrimidine | |
NO152148B (en) | WEAPON SYSTEM WITH CYLINDER MECHANISM | |
GB2054566A (en) | 1-aryl-4-arylsulphonyl-3-aminopropoxy-1h-pyrazoles medicaments containing them and processes for their preparation | |
DK143552B (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF SUBSTITUTED PHENYL ACETIC ACID DERIVATIVES | |
CA1053257A (en) | Anti-inflammatory and analgesic stilbene derivatives | |
US4234742A (en) | Bis-(aryloxycarboxylic acid) compounds | |
NO121611B (en) | ||
US4500731A (en) | Derivatives of 4-phenyl-4-oxobuten-2-oic acid, pharmaceutical compositions containing them, and therapeutic uses for them | |
IE57702B1 (en) | P-oxybenzoic acid derivatives,methods for preparing them and their use for the preparation of medicaments with hypolipemic activity | |
US4183954A (en) | Benzoic acid derivatives and therapeutic composition containing the same | |
US4473583A (en) | Compositions containing certain derivatives of 4-phenyl-4-oxobuten-2-oic acid and methods of treatment using them | |
US4254056A (en) | 2-Aminomethyl phenol derivative and process for preparing thereof | |
NO118798B (en) | ||
US4118504A (en) | Isoindoline derivatives for treating pain | |
JPS6176476A (en) | Xanthone derivative | |
US4247555A (en) | 4,9-Dihydro-9-oxo-N-1H-tetrazol-5-yl-pyrazolo[5,1-b]-quinazoline-2-carboxamides and antiallergic compositions and methods using them | |
US4362891A (en) | Alkanoic acid derivatives | |
DK147973B (en) | ANALOGY PROCEDURE FOR PREPARING 1,4-DIPHENYL-3-PYRAZOLYL ACETIC ACIDS | |
US4163859A (en) | Phenoxyldialkyl acetic acids and esters | |
US3389170A (en) | 3-acylamino-2, 4, 6-triiodo-benzoic acids | |
US3352903A (en) | Phenylalkanoic acids | |
NO131672B (en) | ||
CN111978264B (en) | Industrial production method of deferasirox |